Document:

EX-10.17

 Exhibit 10.17 

 
  

 
 SHARE SUBSCRIPTION AGREEMENT

 between 

ECMOHO LIMITED, 
 and

 EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO 

Dated as of August 7, 2018 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	
	ARTICLE I	 
	
	SUBSCRIPTION OF SHARES	 
			
	 1.1
	 	Subscription of Shares	  	 	1	 
	 1.2
	 	Closing; Delivery	  	 	1	 
	 1.3
	 	Defined Terms Used in this Agreement	  	 	1	 
	
	 ARTICLE II
	  

	
	 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  

			
	 2.1
	 	Organization, Good Standing, Corporate Power and Qualification	  	 	4	 
	 2.2
	 	Capitalization	  	 	4	 
	 2.3
	 	Authorization	  	 	5	 
	 2.4
	 	Valid Issuance of Shares	  	 	5	 
	
	 ARTICLE III
	  

	
	 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
	  

			
	 3.1
	 	Authorization	  	 	5	 
	 3.2
	 	Purchase Entirely for Own Account	  	 	6	 
	 3.3
	 	Disclosure of Information	  	 	6	 
	 3.4
	 	Restricted Securities	  	 	6	 
	 3.5
	 	No Public Market	  	 	6	 
	 3.6
	 	Legends	  	 	6	 
	 3.7
	 	Accredited Investor	  	 	7	 
	 3.8
	 	Foreign Investors	  	 	7	 
	 3.9
	 	No General Solicitation	  	 	7	 
	 3.10
	 	Exculpation Among Investors	  	 	7	 
	 3.11
	 	Residence	  	 	7	 
	
	 ARTICLE IV
	  

	
	 CONDITIONS TO THE INVESTORS’ OBLIGATIONS AT
CLOSING
	  

			
	 4.1
	 	Representations and Warranties	  	 	7	 
	 4.2
	 	Performance	  	 	8	 
	 4.3
	 	Qualifications	  	 	8	 
	 4.4
	 	Investors Rights Agreement	  	 	8	 
	 4.5
	 	Proceedings and Documents	  	 	8	 
	
	 ARTICLE V
	  

	
	 CONDITIONS OF THE COMPANY’S OBLIGATIONS AT
CLOSING
	  

			
	 5.1
	 	Representations and Warranties	  	 	8	 
	 5.2
	 	Performance	  	 	8	 
	 5.3
	 	Qualifications	  	 	8	 

  
 i 

							
	
	 ARTICLE VI
	  

	
	 MISCELLANEOUS
	  

			
	 6.1
	 	Amendment; Waiver	  	 	8	 
	 6.2
	 	Expenses	  	 	9	 
	 6.3
	 	Counterparts	  	 	9	 
	 6.4
	 	Governing Law and Venue; Specific Performance	  	 	9	 
	 6.5
	 	Notices	  	 	10	 
	 6.6
	 	Entire Agreement	  	 	10	 
	 6.7
	 	Confidentiality	  	 	11	 
	 6.8
	 	No Third-Party Beneficiaries	  	 	12	 
	 6.9
	 	Severability	  	 	12	 
	 6.10
	 	Interpretation; Construction	  	 	12	 
	 6.11
	 	Assignment	  	 	13	 
	 6.12
	 	Fulfillment of Obligations	  	 	13	 

 Exhibit A: Schedule of Investors 

Exhibit B: Form of Investors Rights Agreement 

  
 ii 

 SHARE SUBSCRIPTION AGREEMENT 

THIS SHARE SUBSCRIPTION AGREEMENT (including the exhibits hereto, this “Agreement”), dated as of August 7, 2018, is made
between ECMOHO Limited (the “Company”), an exempted company incorporated under the laws of the Cayman Islands and each of the investors listed on Exhibit A attached to this Agreement (each an “Investor” and
together the “Investors”). 
 RECITALS 

WHEREAS, subject to the terms and conditions of this Agreement, the Company desires to issue and sell to each Investor, and each
Investor desires to subscribe for from the Company, that number of Class A-1 Ordinary Shares, US$0.00001 par value per share, and that number of Class A-2 Ordinary Shares, US$0.00001 par value per share, of the Company as set forth
opposite each Investor’s name on Exhibit A (the “Transaction”). The shares of Class A-1 Ordinary Shares and Class A-2 Ordinary Shares issued to the Investors pursuant to this Agreement shall be referred to in
this Agreement as the “Subscribed Shares”); and 
 NOW, THEREFORE, in consideration of the premises, and of
the representations, warranties, covenants and agreements contained herein, the Parties agree as follows: 
 ARTICLE I 

SUBSCRIPTION OF SHARES 

1.1    Subscription of Shares. Subject to the terms and conditions of this Agreement, at the Closing, each Investor
agrees to subscribe for, and the Company agrees to issue and sell to each Investor, that number of Class A-1 Ordinary Shares and Class A-2 Ordinary Shares as set forth opposite such Investor’s name on Exhibit A. 

1.2    Closing; Delivery. 

(a)    The closing of the Transaction (the “Closing”) shall take place remotely via the electronic
exchange of signatures at 10:00 A.M. Hong Kong time on the second business day following the satisfaction or waiver of the last condition set forth in Article IV or Article V to be satisfied or waived, other than those conditions that by their
nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions, or on such other date and at such other time or place as the parties hereto mutually agree (such date, the “Closing Date”).

 (b)    At Closing, the Company shall deliver to each Investor evidence that the Company has made appropriate
book-entry notations reflecting the Class A-1 Ordinary Shares and Class A-2 Ordinary Shares being subscribed for by such Investor at the Closing against payment of the purchase price therefor by wire transfer to a bank account designated
by the Company. 
 1.3    Defined Terms Used in this Agreement. The following terms used in this Agreement shall
be construed to have the meanings set forth or referenced below. 
 (a)    “Affiliate” means, with
respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such specified Person. 

 (b)    “Agreement” has the meaning set forth in the
Preamble. 
 (c)    “Arbitration Rules” has the meaning set forth in Section 6.4(b). 

(d)    “Arbitrator” has the meaning set forth in Section 6.4(b). 

(e)    “Authorization” and collectively, “Authorizations”, mean any consents,
registrations, approvals, permits, clearances or authorizations. 
 (f)    “Board of Directors” means
the board of directors of the Company. 
 (g)    “Business Day” means a day (other than a Saturday or
Sunday or public holiday) on which banks are open for general corporate business in each of Shanghai, People’s Republic of China; George Town, Cayman Islands; Hong Kong; and New York, New York, United States of America. 

(h)    “Class A Ordinary Shares” means a class A ordinary share in the capital of the Company, par value
of US$0.00001 per share. 
 (i)    “Class A-1 Ordinary Shares” means a class A-1 ordinary share in the
capital of the Company, par value of US$0.00001 per share. 
 (j)    “Class A-2 Ordinary Shares” means
a class A-2 ordinary share in the capital of the Company, par value of US$0.00001 per share. 
 (k)    “Class B
Ordinary Shares” means a class B ordinary share in the capital of the Company, par value of US$0.00001 per share. 

(l)    “Closing” has the meaning set forth in Section 1.2(a). 

(m)    “Closing Date” has the meaning set forth in Section 1.2(a). 

(n)    “Code” means the United States Internal Revenue Code of 1986, as amended. 

(o)    “Company” has the meaning set forth in the Preamble. 

(p)    “Confidential Information” has the meaning set forth in Section 6.7(a). 

(q)    “Constitutive Documents” means, with respect to a Person, such Person’s certificate of
incorporation, formation or registration (including, if relevant, certificates of change of name), memorandum of association, articles of association or incorporation, charter, by-laws, trust deed, trust instrument or equivalent documents, in each
case as amended. 
 (r)    “Filing” and collectively, “Filings”, mean notices,
reports, applications, forms, expert opinions or other filings or information. 
 (s)    “Governmental
Entity” and collectively, “Governmental Entities”, means any governmental or regulatory authority, agency, commission, body, court or other legislative, executive or judicial governmental entity. 

(t)    “HKIAC” means the Hong Kong International Arbitration Centre. 

  
 -2- 

 (u)    “Investor” and collectively,
“Investors”, have the meaning set forth in the Preamble. 
 (v)    “Investors Rights
Agreement” means the agreement among the Company, the Investors and certain other shareholders of the Company, dated as of the date of the Closing Date, in the form of Exhibit B attached to this Agreement. 

(w)    “Knowledge”, including the phrase “to the Company’s knowledge”, shall mean
the actual knowledge of the following officers: the chief executive officer of the Company. 

(x)    “Lien” means any lien, charge, pledge, security interest, claim or other encumbrance. 

(y)    “Material Adverse Effect” means a material adverse effect on the business, assets, liabilities,
financial condition, property or results of operations; provided, however, that in no event shall any of the following exceptions, alone or in combination with the other enumerated exceptions below, be deemed to constitute a Material
Adverse Effect: (i) any change resulting from the execution or delivery of this Agreement or the Investors Rights Agreement, the consummation of the Transaction or the announcement or other publicity with respect to the foregoing, (ii) any
legal, regulatory or other change affecting any of the industries, industry sectors or geographic sectors (including, for the avoidance of doubt, the PRC) in which the Company operates, (iii) any change or prospective change in law or
accounting standards or interpretations or the enforcement thereof applicable to the Company, (iv) any change in domestic or foreign economic, political, demographic or business conditions or financial, credit, debt or securities market
conditions generally, (v) any change that results from (A) acts of war (whether or not declared), hostilities, sabotage, terrorism, military actions, cyberwarfare, other armed conflicts or the escalation of any of the foregoing,
(B) any hurricane, super storm, flood, tornado, earthquake or other natural disaster, (C) any pandemic, (D) environmental change, or (E) any other force majeure event, or (vi) any failure by the Company to meet any
internal or public projections, budgets, forecasts, plans or guidance. 
 (z)    “Ordinary Shares”
means the ordinary shares of the Company, including the Class A Ordinary Shares and the Class B Ordinary Shares. 

(aa)    “Party” and collectively, “Parties”, mean the signatories to this Agreement.

 (bb)    “Person” means any individual, corporation, partnership, trust, limited liability company,
association or other entity. 
 (cc)    “PRC” means the People’s Republic of China but, solely for
purposes of this Agreement and the other Transaction Agreements, does not include Hong Kong, the Special Administrative Region of Macau and the territory of Taiwan. 

(dd)    “Preferred Shares” means the preferred shares of the Company. 

(ee)    “Representatives” means a director, officer, employee, shareholder, partner, member, accountant,
agent, counsel and other representatives of a specified Person. 
 (ff)    “SEC” means the U.S.
Securities and Exchange Commission. 
 (gg)    “Securities Act” means the U.S. Securities Act of 1933,
as amended. 

  
 -3- 

 (hh)    “Series A Preferred Shares” means the preferred
shares of the Company designated as series A. 
 (ii)    “Share Plan” means the 2018 Employee Share
Option Plan duly adopted by the Board of Directors and approved by the Company. 
 (jj)    “Subscribed
Shares” has the meaning set forth in the Recitals. 
 (kk)    “Transaction” has the meaning
set forth in the Recitals. 
 (ll)    “Transaction Agreements” means this Agreement and the Investors
Rights Agreement. 
 (mm)    “U.S. Dollars” or “US$” means United States dollars, the
lawful currency of the United States of America. 
 ARTICLE II 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company hereby represents and warrants to each Investor that the following representations are true and complete as of the date hereof,
except as otherwise indicated: 
 2.1    Organization, Good Standing, Corporate Power and Qualification. The
Company is duly organized and validly existing under the laws of the Cayman Islands and in good standing and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The
Company is duly qualified to transact business in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect. The Constitutive Documents of the Company are in full force and effect under, and in compliance with, the
laws of the Cayman Islands. 
 2.2    Capitalization. 

(a)    The authorized capital of the Company consists, as of the date hereof, of: 

(i)    9,519,000 shares of Class A-1 Ordinary Shares, none of which are issued and outstanding
immediately prior to the Closing. 
 (ii)    13,663,700 shares of Class A-2 Ordinary Shares, none of
which issued and outstanding immediately prior to the Closing. 
 (iii)    4,880,496,457 shares of
Class A Ordinary Shares, 15,531,000 shares of which are issued and outstanding immediately prior to the Closing. All of the outstanding shares of Class A Ordinary Shares have been duly authorized, are fully paid and nonassessable. 

(iv)    75,150,400 shares of Class B ordinary shares, 75,150,400 shares of which are issued and outstanding
immediately prior to the Closing. All of the outstanding shares of Class B Ordinary Shares have been duly authorized, are fully paid and nonassessable. 

  
 -4- 

 (v)    21,170,443 shares of Preferred Shares, of which
21,170,443 shares have been designated Series A Preferred Shares, of which none are issued and outstanding immediately prior to the Closing. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the memorandum and
articles of association of the Company and as provided by the laws of the Cayman Islands. 
 (b)    Except for
(i) the conversion privileges of the Preferred Sale Shares, (ii) the right of first offer provided in the Investors Rights Agreement, (iii) the Ordinary Shares reserved for issuance under the Share Plan, and (iv) as contemplated
hereby and by the Memorandum and Articles, there are no options, warrants, conversion privileges, agreements or rights of any kind with respect to the issuance or purchase of the shares of the Company. Apart from the exceptions noted in this
Section 2.2(b) and the Investors Rights Agreement, the Company is not a party to any contract that would subject the shares (including the Preferred Sale Shares) of the Company’s outstanding share capital, or shares issuable upon exercise
or exchange of any outstanding options or other shares issuable by the Company, to any preemptive rights, rights of first refusal or other rights of any kind to purchase such shares (whether in favor of the Company or any other Person). The Company
will reserve 11,386,410 shares of Ordinary Shares for issuance to officers, directors, employees and consultants of the Company pursuant to the Share Plan, among which no shares have been issued as of the date hereof. No arrangement or provision of
the Share Plan and agreements with the management and employees of entities in the PRC relating to the Share Plan will violate any applicable laws of the PRC. 

2.3    Authorization. All corporate action required to be taken by the Company’s Board of Directors and
shareholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Subscribed Shares at the Closing, has been taken or will be taken prior to the Closing. The Transaction Agreements, when executed and delivered
by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies, or (iii) to the extent the indemnification provisions contained in the Investors Rights Agreement may be limited by applicable federal or state securities laws. 

2.4    Valid Issuance of Shares. The Subscribed Shares, when issued, sold and delivered in accordance with the
terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable securities laws
of the United States of America or the Cayman Islands and Liens created by or imposed by an Investor. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE INVESTORS 

Each Investor hereby represents and warrants to the Company, severally and not jointly, that: 

3.1    Authorization. The Investor has full power and authority to enter into the Transaction Agreements. The
Transaction Agreements to which the Investor is a party, when executed and delivered by the Investor, will constitute valid and legally binding obligations of the Investor, enforceable in accordance with their terms, except (a) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies, or (b) to the extent the indemnification provisions contained in the Investors’ Rights Agreement may be limited by applicable federal or state securities laws. 

  
 -5- 

 3.2    Purchase Entirely for Own Account. This Agreement is made
with the Investor in reliance upon the Investor’s representation to the Company, which by the Investor’s execution of this Agreement, the Investor hereby confirms, that the Subscribed Shares to be acquired by the Investor will be acquired
for investment for the Investor’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Investor has no present intention of selling, granting any participation in, or
otherwise distributing the same. By executing this Agreement, the Investor further represents that the Investor does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to
such Person or to any third Person, with respect to any of the Shares. The Investor has not been formed for the specific purpose of acquiring the Shares. 

3.3    Disclosure of Information. The Investor has had an opportunity to discuss the Company’s business,
management, financial affairs and the terms and conditions of the offering of the Subscribed Shares with the Company’s management and has had an opportunity to review the Company’s facilities. The foregoing, however, does not limit or
modify the representations and warranties of the Company in Article II of this Agreement or the right of the Investors to rely thereon. 

3.4    Restricted Securities. The Investor understands that the Subscribed Shares have not been, and will not be,
registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the
Investor’s representations as expressed herein. The Investor understands that the Subscribed Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Investor
must hold the Subscribed Shares indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Investor acknowledges that the Company
has no obligation to register or qualify the Subscribed Shares for resale except as set forth in the Investors’ Rights Agreement. The Investor further acknowledges that if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Subscribed Shares, and on requirements relating to the Company which are outside of the Investor’s control, and which the
Company is under no obligation, and may not be able, to satisfy. 
 3.5    No Public Market. The Investor
understands that no public market now exists for the Subscribed Shares, and that the Company has made no assurances that a public market will ever exist for the Subscribed Shares. 

3.6    Legends. The Investor understands that the Subscribed Shares and any securities issued in respect of or
exchange for the Subscribed Shares, may be notated with one or all of the following legends: 
 “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.” 

  
 -6- 

 (a)    Any legend set forth in, or required by, the other Transaction
Agreements. 
 (b)    Any legend required by the securities laws of any state to the extent such laws are applicable to
the Subscribed Shares represented by the certificate, instrument, or book entry so legended. 
 3.7    Accredited
Investor. The Investor is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. 

3.8    Foreign Investors. If the Investor is not a United States person (as defined by Section 7701(a)(30) of
the Code), the Investor hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Subscribed Shares or any use of this Agreement, including
(i) the legal requirements within its jurisdiction for the purchase of the Subscribed Shares, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained,
and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Subscribed Shares. The Investor’s subscription for and continued beneficial ownership of the
Subscribed Shares will not violate any applicable securities or other laws of the Investor’s jurisdiction. 

3.9    No General Solicitation. Neither the Investor, nor any of its officers, directors, employees, agents,
shareholders or partners has either directly or indirectly, including, through a broker or finder, (a) engaged in any general solicitation, or (b) published any advertisement in connection with the offer and sale of the Subscribed Shares.

 3.10    Exculpation Among Investors. The Investor acknowledges that it is not relying upon any Person in
making its investment or decision to invest in the Company. The Investor agrees that neither any Investor nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Investor shall be liable to any other
Investor for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Subscribed Shares. 

3.11    Residence. If the Investor is an individual, then the Investor resides in the state or province identified
in the address of the Investor set forth on Exhibit A; if the Investor is a partnership, corporation, limited liability company or other entity, then the office or offices of the Investor in which its principal place of business is identified
in the address or addresses of the Investor set forth on Exhibit A. 
 ARTICLE IV 

CONDITIONS TO THE INVESTORS’ OBLIGATIONS AT CLOSING 

The obligations of each Investor to purchase Subscribed Shares at the Closing are subject to the fulfillment, on or before such Closing, of
each of the following conditions, unless otherwise waived: 
 4.1    Representations and Warranties. The
representations and warranties of the Company contained in Section 2 shall be true and correct in all material respects as of the Closing Date. 

  
 -7- 

 4.2    Performance. The Company shall have performed and complied
with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company on or before the Closing Date. 

4.3    Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or
regulatory body of the United States of America or the Cayman Islands that are required in connection with the lawful issuance and sale of the Subscribed Shares pursuant to this Agreement shall be obtained and effective as of such Closing Date. 

4.4    Investors Rights Agreement. The Company shall have executed and delivered the Investors Rights Agreement.

 4.5    Proceedings and Documents. All corporate and other proceedings in connection with the transactions
contemplated at the Closing and all documents incident thereto shall be reasonably satisfactory in form and substance to each Investor, and each Investor (or its counsel) shall have received all such counterpart originals and certified or other
copies of such documents as reasonably requested. Such documents may include good standing certificates. 
 ARTICLE V 

CONDITIONS OF THE COMPANY’S OBLIGATIONS AT CLOSING 

The obligations of the Company to sell Subscribed Shares to the Investors at the Closing are subject to the fulfillment, on or before the
Closing, of each of the following conditions, unless otherwise waived: 
 5.1    Representations and Warranties.
The representations and warranties of each Investor contained in Section 3 shall be true and correct in all material respects as of the Closing Date. 

5.2    Performance. The Investors shall have performed and complied with all covenants, agreements, obligations and
conditions contained in this Agreement that are required to be performed or complied with by them on or before the Closing Date. 

5.3    Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or
regulatory body of the United States of America or the Cayman Islands that are required in connection with the lawful issuance and sale of the Subscribed Shares pursuant to this Agreement shall be obtained and effective as of the Closing Date. 

5.4    Investors Rights Agreement. Each of the Investor shall have executed and delivered the Investors Rights
Agreement. 
 ARTICLE VI 

MISCELLANEOUS 

6.1    Amendment; Waiver. Any provision of this Agreement may be amended or waived if, and only if, such amendment
or waiver is in writing and signed, in the case of an amendment, by each Party, or in the case of a waiver, by the Party against which the waiver is to be effective. No failure or delay by any Party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by Law. 

  
 -8- 

 6.2    Expenses. Each Party shall bear its own fees and expenses
incurred in connection with the preparation, negotiation, execution and performance of this Agreement and the Transaction, including all fees and expenses of its respective Representatives. 

6.3    Counterparts. This Agreement may be executed in any number of counterparts, each such counterpart being
deemed to be an original instrument, and all such counterparts shall together constitute the same agreement. 

6.4    Governing Law and Venue; Specific Performance. 

(a)    THIS AGREEMENT SHALL BE GOVERNED BY AND INTERPRETED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK (INCLUDING SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW), WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW RULES THEREOF THAT WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAW OF ANY OTHER JURISDICTION. 

(b)    Subject to Section 6.4(c), any disputes, actions and proceedings against any Party arising out of or in any way
relating to this Agreement shall be submitted to the HKIAC and resolved in accordance with the arbitration rules of the HKIAC (the “Arbitration Rules”) in force at the relevant time, except as such rules are modified or displaced by
any of the provisions of this Agreement. The official language of the arbitration shall be English and the arbitration tribunal shall consist of three arbitrators (each, an “Arbitrator”). The claimant(s), irrespective of number,
shall nominate jointly one Arbitrator; the respondent(s), irrespective of number, shall nominate jointly one Arbitrator; and a third Arbitrator will be nominated jointly by the first two Arbitrators and shall serve as chairman of the arbitration
tribunal. In the event the claimant(s) or respondent(s) or the first two Arbitrators shall fail to nominate or agree to the joint nomination of an Arbitrator or the third Arbitrator, as applicable, within the time limits specified by the Arbitration
Rules, such Arbitrator shall be appointed promptly by the HKIAC. The arbitration tribunal shall have no authority to award punitive or other punitive-type damages. The award of the arbitration tribunal shall be final and binding upon the disputing
parties and, in the case of any award of monetary damages, shall be denominated in U.S. dollars. Any Party to an award may apply to any court of competent jurisdiction for enforcement of such award and, for purposes of the enforcement of such award,
the Parties irrevocably and unconditionally submit to the jurisdiction of any court of competent jurisdiction and waive any defenses to such enforcement based on lack of personal jurisdiction or inconvenient forum. 

(c)    Notwithstanding the foregoing, the Parties hereby consent to and agree that in addition to any recourse to
arbitration as set out in this Section 6.4, any Party may, to the extent permitted under the laws of the jurisdiction where application is made, seek an interim injunction from a court or other authority with competent jurisdiction and,
notwithstanding that this Agreement is governed by the laws of the State of New York, a court or authority hearing an application for injunctive relief may apply the procedural law of the jurisdiction where the court or other authority is located in
determining whether to grant the interim injunction. For the avoidance of doubt, this Section 6.4(c) is only applicable to the seeking of interim injunctions and does not restrict the application of Section 6.4(d) in any way. 

  
 -9- 

 (d)    The Parties agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches
of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court having jurisdiction, this being in addition to any other remedy to which such Party is entitled at law or in equity. 

6.5    Notices. Any notice, request, instruction or other document to be given hereunder by any Party to any other
Party or Parties shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by facsimile, e-mail or overnight courier: 

If to any Investors, to the address listed in Exhibit A for such Investor. 

If to the Company: 
 ECMOHO
Limited 
 2F/3F, Xuhuiyuan Building No. 1000, 

Tianyaoqiao Road, Xuhui District, 

Shanghai, People’s Republic of China. 

Attention: Richard Wei 
 e-mail:
richard@ecmoho.com 
 (with a copy to: 

Sullivan & Cromwell, 

Level 32, 
 101 Collins Street,

 Melbourne, Victoria 3000 

Australia. 
 Attention: Robert Chu

 fax: (+61-3) 9654-2422) 

email: chur@sullcrom.com) 
 or to such other
Persons or addresses as may be designated in writing by the Party to receive such notice. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving Party upon actual receipt, if delivered
personally, three (3) Business Days after deposit in the mail if sent by registered or certified mail, or upon confirmation of successful transmission if sent by facsimile or e-mail; provided, that if given by facsimile or e-mail, such
notice, request, instruction or other document shall be confirmed by the receiving party within one (1) Business Day of receipt by dispatch pursuant to one of the other methods described herein or on the next Business Day after deposit with an
overnight courier. 
 6.6    Entire Agreement. This Agreement (including any exhibits and schedules hereto)
constitutes the entire agreement and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the Parties, with respect to the subject matter hereof. EACH PARTY AGREES THAT, EXCEPT FOR THE
REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT, NEITHER THE INVESTOR NOR THE COMPANY MAKES OR RELIES ON ANY OTHER REPRESENTATIONS, WARRANTIES OR INDUCEMENTS, AND EACH HEREBY DISCLAIMS ANY OTHER REPRESENTATIONS, WARRANTIES OR INDUCEMENTS,
EXPRESS OR IMPLIED, AS TO THE ACCURACY OR COMPLETENESS OF ANY OTHER INFORMATION, MADE BY, OR MADE AVAILABLE BY, ITSELF OR ANY OF ITS REPRESENTATIVES, WITH RESPECT TO, OR IN CONNECTION WITH, THE NEGOTIATION, EXECUTION OR DELIVERY OF THIS AGREEMENT OR
THE CONSUMMATION OF THE TRANSACTION, NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE OTHER PARTY OR THE OTHER PARTY’S REPRESENTATIVES OF ANY DOCUMENTATION OR OTHER INFORMATION WITH RESPECT TO ANY ONE OR MORE OF THE FOREGOING; PROVIDED,
HOWEVER, THAT NONE OF THE FOREGOING SHALL OPERATE TO LIMIT THE LIABILITY OF ANY OTHER PERSON IN RESPECT OF ANY CLAIM OR CAUSE OF ACTION BASED ON OR ARISING OUT OF FRAUD. NO PARTY SHALL BE BOUND BY, OR BE LIABLE FOR, ANY ALLEGED
REPRESENTATION, PROMISE, INDUCEMENT OR STATEMENT OF INTENTION NOT CONTAINED HEREIN. 

  
 -10- 

 6.7    Confidentiality. 

(a)    Each of the Parties shall, and shall cause its Affiliates and its and their respective Representatives to, keep
confidential and not use or disclose any information provided by the other Party or the Company (whether oral, written or in any other form), which the other Party or the Company has provided prior to the date of this Agreement or may provide to the
Investor subsequent to the date of this Agreement, and any information derived by the Investor from such information, including the existence and terms and conditions of this Agreement (collectively, the “Confidential Information”).
Confidential Information shall not include information that: 
 (i)    is publicly available or becomes
publicly available without the breach of any obligations of confidentiality by the receiving Party; 

(ii)    was in possession of the receiving Party, having been acquired without the breach of any
obligations of confidentiality, prior to it being furnished to the receiving Party; or 
 (iii)    was
independently and lawfully acquired by the receiving Party without the breach of any obligations of confidentiality. 

(b)    Each Party may disclose Confidential Information to its Affiliates and its and their respective Representatives
subject to the condition that they: 
 (i)    need to know the Confidential Information for purposes of
the activities contemplated by this Agreement; 
 (ii)    are informed of the confidential nature of the
Confidential Information; and 
 (iii)    are bound by confidentiality obligations to the same extent as
set forth in this Section 6.7. 
 (c)    If a Party becomes legally compelled (by deposition, interrogatory,
request for documents, subpoena, civil investigative demand or similar process) to disclose any of the Confidential Information, it shall provide the other Party with prompt prior written notice and may disclose only that portion of the Confidential
Information that is legally required and shall exercise reasonable efforts to obtain assurance that confidential treatment shall be accorded to such Confidential Information; provided, that the failure to obtain such assurance of confidential
treatment shall not limit or restrict any disclosures otherwise permitted under this Section 6.7. If a Party is required by applicable securities laws or rules or regulations of each stock exchange upon which the securities of a Party or the
Company are listed or pursuant to a request by any other regulatory or Governmental Entity in any jurisdiction to disclose any of the Confidential Information, such Party shall as far as reasonably practicable, and to the extent permitted by law,
make such disclosure only after prior consultation with the other Party and after giving the other Party a reasonable opportunity to comment on the proposed disclosure. 

  
 -11- 

 (d)    All Confidential Information provided by a Party shall be and
shall remain the property of such Party or, as the case may be, the Company. Each Party shall, and shall cause its Affiliates and its and their respective Representatives to, subject to applicable Laws, within ten (10) days following a request
by the other Party, return to such Party all Confidential Information and all reproductions of Confidential Information, or promptly destroy such Confidential Information or reproductions thereof in any form (except that if such Confidential
Information or any reproduction thereof is in electronic form, a Party shall only be required to destroy such Confidential Information or any reproduction thereof to the extent permitted by applicable Laws and reasonably practicable) and deliver to
the other Party a certificate signed by a senior officer of the receiving Party confirming compliance with this Section 6.7. In the case of such Confidential Information that is not returned or destroyed, the Investor shall continue to keep
such information confidential pursuant to the terms of this Section 6.7 and shall not use such Confidential Information for purposes other than the compliance with such Laws. 

6.8    No Third-Party Beneficiaries. Each Party hereby agrees that its representations, warranties and covenants
set forth herein are solely for the benefit of the other Party, in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any Persons other than the Parties any rights or remedies
hereunder, including the right to rely upon the representations and warranties set forth herein. 

6.9    Severability. The provisions of this Agreement shall be deemed severable and the invalidity or
unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or
unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of
this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such
provision, or the application of such provision, in any other jurisdiction. 
 6.10    Interpretation;
Construction. 
 (a)    The table of contents and headings herein are for convenience of reference only, do not
constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to an annex, exhibit, section or schedule, such reference shall be to an annex, exhibit,
section or schedule to this Agreement unless otherwise indicated. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words
“without limitation”. 
 (b)    The Parties have participated jointly in negotiating and drafting this
Agreement. In the event that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party
by virtue of the authorship of any provision of this Agreement. 

  
 -12- 

 6.11    Assignment. No Party may assign any of its rights or
delegate any of its obligations under this Agreement, by operation of Law or otherwise, without the prior written consent of the other Party, except that the Investor may assign any and all of its rights under this Agreement to one or more of its
wholly-owned Subsidiaries (but no such assignment shall relieve the Investor of any of its obligations hereunder). Any purported assignment in violation of this Agreement is void. 

6.12    Fulfillment of Obligations. Any obligation of any Party to any other Party under this Agreement, which
obligation is performed, satisfied or fulfilled completely by an Affiliate of such Party, shall be deemed to have been performed, satisfied or fulfilled by such Party. 

[Signature Page Follows]  

  
 -13- 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	ECMOHO LIMITED
		
	By:	 	 /s/ ZENG QINGCHUN

		
	Name:	 	 ZENG QINGCHUN

		 	(print)
		
	Title:	 	Director
		
	Address:	 	

 SIGNATURE PAGE TO SHARE
SUBSCRIPTION AGREEMENT 

 
			
	INVESTORS:
	
	 CID GREATER CHINA FUND V, L.P.

	(Print Name of Investor)
		
	By:	 	 /s/ Steven C.Y. Chang

		
	Name:	 	 Steven C.Y. Chang

		 	(print)
		
	Title:	 	Director
		
	Address:	 	

 SIGNATURE PAGE TO SHARE
SUBSCRIPTION AGREEMENT 

 
			
	INVESTORS:
	
	 STCH INVESTMENT, INC.

	(Print Name of Investor)
		
	By:	 	 /s/ Steven C.Y. Chang

		
	Name:	 	 Steven C.Y. Chang

		 	(print)
		
	Title:	 	Director
		
	Address:	 	

 SIGNATURE PAGE TO SHARE
SUBSCRIPTION AGREEMENT 

 
			
	INVESTORS:
	
	 SMART WARRIOR LIMITED

	(Print Name of Investor)
		
	By:	 	 /s/ NG YUM FAI

		
	Name:	 	 NG YUM FAI

		 	(print)
		
	Title:	 	Director
		
	Address:	 	Vistra Corporate Services Centre
		 	Wickhams Cay II
		 	Road Town
		 	Tortola
		 	VG1110
		 	Virgin Islands, British

 SIGNATURE PAGE TO SHARE
SUBSCRIPTION AGREEMENT 

 
			
	INVESTORS:
	
	 Canarywharf Capital Limited

	(Print Name of Investor)
		
	By:	 	 /s/ YIJUN TANG

		
	Name:	 	 YIJUN TANG

		 	(print)
		
	Title:	 	Director
		
	Address:	 	Coastal Building, Wickham’s Cay II,
	P.O. Box 2221, Road Town, Tortola, British
	Virgin

 SIGNATURE PAGE TO SHARE
SUBSCRIPTION AGREEMENT 

 EXHIBIT A 

SCHEDULE OF INVESTORS 
  

															
	 Investor
	  	 Address of

Investor
	  	Number of
Class A-1
Ordinary
Shares	 	  	Price Per
Class A-1
Ordinary
Shares	 	  	Purchase Price	 
	 CID Greater China Fund V, L.P.
	  	 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman Islands
	  	 	4,759,500	 	  	US$	0.1709	 	  	US$	813,474	 
					
	 STCH Investment, Inc.
	  	 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman Islands
	  	 	4,759,500	 	  	US$	0.1709	 	  	US$	813,474	 

  
 A-1 

															
	 Investor
	  	 Address of
Investor
	  	Number of
Class A-2
Ordinary
Shares	 	  	Price Per
Class A-2
Ordinary
Shares	 	  	Purchase Price	 
	 CID Greater China Fund V, L.P.
	  	 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman Islands
	  	 	1,423,300	 	  	US$	0.1709	 	  	US$	243,263	 
					
	 STCH Investment Inc.
	  	 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman Islands
	  	 	1,423,300	 	  	US$	0.1709	 	  	US$	243,263	 
					
	 Smart Warrior Limited
	  	 Vistra Corporate Services Centre, Wickham’s Cay II, Tortola, VG 1110, British Virgin
Islands
	  	 	5,693,200	 	  	US$	0.1709	 	  	US$	973,054	 
					
	 Canarywharf Capital Limited
	  	 Coastal Building, Wickham’s Cay II, P.O. Box 2221, Road Town, Tortola, British
Virgin Islands
	  	 	2,277,300	 	  	US$	0.1709	 	  	US$	389,222	 

  
 A-2 

 EXHIBIT B 

FORM OF INVESTORS RIGHTS AGREEMENT 

  
 B-1 

  

 
 INVESTORS RIGHTS AGREEMENT

 by and among 

ECMOHO LIMITED, 

BEHEALTH LIMITED, 

UHEALTH LIMITED, 

ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, 

SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., 

WANG YING, 
 ZENG
QINGCHUN 
 and 

EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO 

Dated as of [●], 2018 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
			
		  	ARTICLE I.	  			
			
		  	INTRODUCTORY MATTERS	  			
			
	1.1	  	Defined Terms	  	 	2	 
	1.2	  	Interpretation; Construction	  	 	8	 
			
		  	ARTICLE II.	  			
			
		  	DEMAND REGISTRATION	  			
			
	2.1	  	Right to Request Demand Registration	  	 	8	 
	2.2	  	Effective Demand Registration	  	 	8	 
	2.3	  	Number of Demand Registrations	  	 	9	 
	2.4	  	Selection of Underwriters	  	 	9	 
	2.5	  	Priority on Demand Registrations	  	 	9	 
	2.6	  	Effective Period of Demand Registrations	  	 	9	 
			
		  	ARTICLE III.	  			
			
		  	PIGGYBACK REGISTRATION	  			
			
	3.1	  	Right to Request a Piggyback Registration	  	 	9	 
	3.2	  	Selection of Underwriters	  	 	10	 
	3.3	  	Priority on Primary Piggyback Registrations	  	 	10	 
	3.4	  	Priority on Secondary Piggyback Registrations	  	 	10	 
	3.5	  	Basis of Participation	  	 	11	 
			
		  	ARTICLE IV.	  			
			
		  	F-3 REGISTRATION	  			
			
	4.1	  	Right to Request F-3 Registration	  	 	11	 
	4.2	  	Effective F-3 Registration	  	 	11	 
	4.3	  	Number of F-3 Registrations	  	 	11	 
	4.4	  	Selection of Underwriters	  	 	11	 
	4.5	  	Priority on F-3 Registrations	  	 	12	 
	4.6	  	Effective Period of F-3 Registrations	  	 	12	 

  
 i 

							
			
		  	ARTICLE V.	  			
			
		  	SUSPENSION PERIOD	  			
			
	5.1	  	Suspension Period	  	 	12	 
	5.2	  	Additional Registration Rights	  	 	13	 
			
		  	ARTICLE VI.	  			
			
		  	REGISTRATION EXPENSES	  			
			
	6.1	  	Registration Expenses	  	 	13	 
	6.2	  	Termination of Registration Rights	  	 	13	 
			
		  	ARTICLE VII.	  			
			
		  	MANAGEMENT AND INFORMATION RIGHTS	  			
			
	7.1	  	Delivery of Financial Statements	  	 	13	 
	7.2	  	Inspection Rights	  	 	14	 
	7.3	  	Termination of Information Rights	  	 	14	 
	7.4	  	Confidentiality	  	 	14	 
			
		  	ARTICLE VIII.	  			
			
		  	RIGHTS AND RESTRICTIONS REGARDING SHARE TRANSFERS	  			
			
	8.1	  	Right of First Offer	  	 	15	 
	8.2	  	Right of First Refusal	  	 	16	 
	8.3	  	Co-Sale Right	  	 	18	 
	8.4	  	Prohibited Transfers	  	 	19	 
	8.5	  	Restrictions on Issuance by Group Company	  	 	20	 
	8.6	  	Founder Transfers	  	 	20	 
	8.7	  	Termination of Rights and Restrictions	  	 	20	 
			
		  	ARTICLE IX.	  			
			
		  	DRAG-ALONG OBLIGATION	  			
			
	9.1	  	Drag-Along Rights	  	 	20	 
	9.2	  	Termination of Drag-Along Rights	  	 	22	 
			
		  	ARTICLE X.	  			
			
		  	GOVERNANCE AND ADDITIONAL COVENANTS	  			
			
	10.1	  	Board of Directors	  	 	22	 
	10.2	  	Matters Requiring Requisite Approval	  	 	23	 

  
 ii 

							
	10.3	  	Matters Requiring Approval of the Board of Directors	  	 	24	 
	10.4	  	Insurance	  	 	25	 
	10.5	  	Termination of Covenants	  	 	25	 
			
		  	ARTICLE XI.	  			
			
		  	CONFIDENTIALITY	  			
			
	11.1	  	Confidentiality	  	 	25	 
	11.2	  	Damages Not an Adequate Remedy	  	 	27	 
	11.3	  	Survival	  	 	27	 
			
		  	ARTICLE XII.	  			
			
		  	NON-COMPETITION; NON-SOLICITATION	  			
			
	12.1	  	Non-Competition	  	 	27	 
	12.2	  	Non-Solicitation	  	 	28	 
			
		  	ARTICLE XIII.	  			
			
		  	MISCELLANEOUS AND GENERAL	  			
			
	13.1	  	Amendment; Waiver	  	 	28	 
	13.2	  	Counterparts	  	 	29	 
	13.3	  	Governing Law and Venue; Specific Performance	  	 	29	 
	13.4	  	Notices	  	 	30	 
	13.5	  	Entire Agreement	  	 	30	 
	13.6	  	No Third-Party Beneficiaries	  	 	31	 
	13.7	  	Severability	  	 	31	 
	13.8	  	Assignment	  	 	31	 
	13.9	  	Fulfillment of Obligations	  	 	31	 
	13.10	  	Termination	  	 	32	 

  

			
	Exhibit A:	 	Schedule of Investors
		
	Exhibit B:	 	Form of Joinder Agreement

  
 iii 

 INVESTORS RIGHTS AGREEMENT 

THIS INVESTORS RIGHTS AGREEMENT (including the exhibits hereto, this “Agreement”), dated as of
[●], 2018 (the “Execution Date”), is made by and among: 
  

	1.	 ECMOHO Limited (the “Company”), an exempted company incorporated under the laws of the Cayman
Islands; 

  

	2.	 ECMOHO (Hong Kong) Health Technology Limited (“ECMOHO Hong Kong”), a limited company
incorporated under the laws of Hong Kong; 

  

	3.	 Shanghai ECMOHO Health Biotechnology Co., Ltd.
(上海易恒健康生物科技有限公司) (“ECMOHO Shanghai”), a limited liability company established
under the laws of the People’s Republic of China; 

  

	4.	 Founders (as defined below) and Founder Holding Companies (as defined below); and 

 

	5.	 each of the investors listed on Exhibit A, as amended from time to time, attached to this Agreement
(each, an “Investor” and together, the “Investors”). 

 The Company, ECMOHO Hong Kong,
ECMOHO Shanghai and their respective Subsidiaries (as defined below) are referred to collectively herein as the “Group Companies”, and each a “Group Company”. “Group” refers to all the Group
Companies collectively. All of the signatories to this Agreement are collectively referred to as the “Parties” and each individually as a “Party”. 

RECITALS 

WHEREAS, CID Greater China Fund V, L.P. (“CID”), STCH Investment Inc. (“STCH”, and together with CID,
the “Round A Investors”), certain other investors and Shanghai ECMOHO Health Biotechnology Co, Ltd. (“ECMOHO Shanghai”) are parties to a shareholders agreement, dated as of August 18, 2015 (the “Round A
Shareholders Agreement”); 
 WHEREAS, Smart Warrior Limited, CID, STCH, [Yi Hao] (together, the “Round B
Investors”), certain other investors and ECMOHO Shanghai are parties to a shareholders agreement, dated as of April 19, 2016 (the “Round B Shareholders Agreement”); 

WHEREAS, on July [●], 2018, the Company issued certain number of shares of Class A Ordinary Shares to
Best Winner Limited, Lake Zurich Partners Limited and Liberal Rich Limited; 
 WHEREAS, on July [●], 2018,
the Company issued certain number of shares of Class B Ordinary Shares to the Founder Holding Companies (as defined below); 

WHEREAS, the Round A Investors, the Round B Investors and the Company are parties to a share subscription agreement, dated as of
[●], 2018 (the “Round A and B Share Subscription Agreement”), pursuant to which the Company agreed to sell, and each of the Round A Investors and Round B Investors agreed to subscribe for, that number of
Class A-1 and Class A-2 Ordinary Shares of the Company, set forth opposite such Round A Investor’s or Round B Investor’s name on exhibit A thereto; 

 WHEREAS, the Company and certain of the Investors (the “Round C
Investors”) are parties to a Series A preferred share purchase agreement, dated as of August 2, 2018 (the “Series A Share Purchase Agreement”), pursuant to which the Company agreed to sell, and the Round C Investors
agreed to purchase, that number of shares of Series A Preferred Shares of the Company (the “Series A Preferred Shares”), set forth opposite such Round C Investor’s name on exhibit A thereto; 

WHEREAS, Behealth Limited, Delta Capital Growth Fund II, L.P. and
李水莲 have entered into an ordinary share purchase agreement, dated as of August 2, 2018 (the
“Ordinary Share Purchase Agreement”), pursuant to which Behealth Limited agreed to sell, and each of Delta Capital Growth Fund II, L.P. and 李水莲 agreed to purchase, a certain number of shares of Class A Ordinary Shares of the Company; and 

WHEREAS, the Parties desire to address certain relationships among themselves with respect to registration rights and certain
other matters. 
 NOW, THEREFORE, in consideration of the premises, and of the representations, warranties, covenants
and agreements contained herein, the Parties agree as follows: 
 ARTICLE I. 

INTRODUCTORY MATTERS 

1.1     Defined Terms. As used in this Agreement: 

(a)     “ADSs” are American depositary shares of the Company; 

(b)     “Affiliate” means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under common control with, such specified Person; 

(c)     “Affiliate Investor”, and collectively, “Affiliate Investors”, mean CID, STCH
and Delta, (i) in the case of CID or STCH, so long as it owns at least 50% of the Shares that CID or STCH, as applicable, owns immediately following the closing of the Round A and B Share Subscription Agreement, and (ii) in the case of
Delta, so long as it owns at least 50% of the Shares that Delta owns immediately following the closing of the Series A Share Purchase Agreement. 

(d)     “Affiliate Transferee” has the meaning set forth in Section 13.8; 

(e)     “Agreement” has the meaning set forth in the Preamble; 

(f)     “Arbitration Rules” means the arbitration rules of the Hong Kong International Arbitration
Centre; 

  
 -2- 

 (g)     “Arbitrator” has the meaning set forth in
Section 13.3(b); 
 (h)     “Big 4 Accounting Firm” refers to any of Deloitte Touche
Tohmatsu Limited, Ernst & Young, KPMG and PricewaterhouseCoopers; 
 (i)     “Board of
Directors” means the board of directors of the Company; 
 (j)     “Budget” has the meaning
set forth in Section 7.1(b); 
 (k)     “Business Day”, and collectively, “Business
Days”, mean a day (other than a Saturday or Sunday or public holiday) on which banks are open for general corporate business in each of Shanghai, People’s Republic of China; George Town, Cayman Islands; Hong Kong; and New York, United
States of America; 
 (l)     “CID” means CID Greater China Fund V, L.P.; 

(m)     “Class A Ordinary Share” means a class A ordinary share in the capital of the Company, par value
of US$0.00001 per share; 
 (n)     “Class B Ordinary Share” means a class B ordinary share in the
capital of the Company, par value of US$0.00001 per share; 
 (o)     “Company” has the meaning set
forth in the Preamble; 
 (p)     “Competitor” means a Person engaged, directly or indirectly
(including through any partnership, limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in the health and wellness related e-commerce industry in the Chinese market, but shall not
include any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than twenty percent (20%) of the outstanding equity of any Competitor; 

(q)     “Constitutive Documents” means, with respect to a Person, such Person’s certificate of
incorporation, formation or registration (including, if relevant, certificates of change of name), memorandum of association, articles of association or incorporation, charter, bylaws, trust deed, trust instrument, or equivalent documents, in each
case as amended; and means, with respect to limited liability companies of the People’s Republic of China, articles of association or equivalent documents; 

(r)     “Control”, including the correlative terms “controlling”, “controlled
by” and “under common control with”, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of an entity, whether through ownership of voting securities, by
contract or otherwise; 
 (s)     “Deemed Liquidation Event” has the meaning set forth in the
Memorandum and Articles; 
 (t)     “Delta” means Delta Capital Growth Fund II, L.P.; 

  
 -3- 

 (u)     “Demand Registration” has the meaning set forth
in Section 2.1; 
 (v)     “Derivative Securities” means any securities or rights
convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Ordinary Shares, including options and warrants. 

(w)     “Designated Holders” means each of the Investors and each of their respective Affiliate
Transferees; 
 (x)     “ECMOHO Hong Kong” means ECMOHO (Hong Kong) Health Technology Limited, a
limited company established under the Laws of Hong Kong; 
 (y)     “ECMOHO Shanghai” means Shanghai
ECMOHO Health Biotechnology Co, Ltd. (上海易恒健康生物科技有限公司), a limited liability company established under the Laws of the PRC; 

(z)     “Employee Share Option Plan” means the 2018 Employee Share Option Plan duly adopted by the Board
of Directors and approved by the Company; 
 (aa)     “Exchange Act” means the U.S. Securities Exchange
Act of 1934, as amended; 
 (bb)     “Execution Date” has the meaning set forth in the Preamble; 

(cc)     “F-3 Registration” has the meaning set forth in Section 4.1; 

(dd)     “Founders” means Ying WANG
(王影) (PRC identification number: *** and Qingchun
Zeng(曾庆春) (PRC identification number: ***); 

(ee)     “Founder Holding Companies” means Behealth Limited and Uhealth Limited; 

(ff)     “Fully Exercising Investor” has the meaning set forth in Section 8.1(b); 

(gg)     “Governmental Entity” means any U.S. or non-U.S. governmental or regulatory authority, agency,
commission, body, court or other legislative, executive or judicial governmental entity; 
 (hh)    
“HKIAC” means the Hong Kong International Arbitration Centre; 
 (ii)     “IFRS” means
the International Financial Reporting Standards issued by the International Accounting Standards Board; 
 (jj)    
“Investor” has the meaning set forth in the Preamble; 
 (kk)     “Investor Beneficial
Owners” has the meaning set forth in Section 8.1; 

  
 -4- 

 (ll)     “Investor Director”, and collectively,
“Investor Directors”, means any of the Preferred Share Director, the Round A Director and the Round B Director. 

(mm)     “Investor Share”, and collectively, “Investor Shares”, means any Share held by
an Investor. 
 (nn)     “Law”, and collectively, “Laws”, mean any federal, state,
local or foreign law, statute or ordinance, common law, or any rule, regulation, standard, judgment, order, writ, injunction, decree, arbitration award, agency requirement, license or permit of any Governmental Entity; 

(oo)     “Maximum Offering Size” has the meaning set forth in Section 2.5; 

(pp)     “Memorandum and Articles” means the memorandum of association and articles of association of the
Company adopted by a special resolution of the shareholders of the Company on August 2, 2018; 
 (qq)    
“New Securities” means equity securities issued by the Company after the date hereof; provided that securities created pursuant to a stock split, dividend or other subdivision of Ordinary Shares are not New Securities; 

(rr)     “Offer Notice” has the meaning set forth in Section 8.1(a); 

(ss)     “Offered Shares” has the meaning set forth in Section 8.2(a); 

(tt)     “Ordinary Shares” means the ordinary shares of the Company, including the Class A Ordinary
Shares and the Class B Ordinary Shares; 
 (uu)     “Ordinary Share Purchase Agreement” has the meaning
set forth in the Recitals; 
 (vv)     “Original Shares” means ordinary shares with a par value of
US$0.0001 each in the capital of the Company; 
 (ww)     “Party” has the meaning set forth in the
Preamble; 
 (xx)     “Person” means any individual, corporation, partnership, trust, limited liability
company, association or other entity; 
 (yy)     “Piggyback Registration” has the meaning set forth in
Section 3.1; 
 (zz)     “Preferred Share Director” means Greg Ye, as the member of the
Board of Directors appointed by the Round C Investors; 
 (aaa)     “Proposed ROFR Seller” has the
meaning set forth in Section 8.2(a); 
 (bbb)     “Proposed ROFR Purchaser” has the meaning
set forth in Section 8.2(a); 

  
 -5- 

 (ccc)     “Qualified IPO” means a firm-commitment
underwritten initial public offering by the Company of its Ordinary Shares (or the ADSs thereof) on the New York Stock Exchange or NASDAQ Stock Market in the United States, the Hong Kong Stock Exchange or any other exchange in any other jurisdiction
(or any combination of such exchanges and jurisdictions) acceptable to the Company, in any case with a pre-initial public offering valuation of at least US$600,000,000 and with aggregate offering proceeds (before deduction of underwriting fees,
commissions or expenses) to the Company of not less than US$120,000,000 (or any cash proceeds of other currency of equivalent value); 

(ddd)     “Registrable Investor Shares” means, the Investor Shares and any other securities issued or
issuable with respect to such Investor Shares by way of a share split, share dividend, recapitalization, exchange or similar event or otherwise; provided, however, that as to any Investor Share, such Share shall cease to be a
Registrable Investor Share when: (i) a Registration Statement (as defined herein) covering such Registrable Investor Share has been declared effective and such Registrable Investor Share has been disposed of pursuant to such effective
Registration Statement; (ii) such Registrable Investor Share shall have been sold pursuant to Rule 144 (or any similar provision then in effect) under the Securities Act; (iii) such Registrable Investor Share is otherwise transferred
in a private transaction and is no longer held by any Investor; or (iv) such Registrable Investor Share ceases to be outstanding; 

(eee)     “Registrable Shares” means, at any time: (i) any of the Registrable Investor Shares; and
(ii) any Ordinary Shares not previously issued to the public and currently held or hereafter acquired by a Designated Holder, and any other securities issued or issuable with respect to such Ordinary Shares by way of a share split, share
dividend, recapitalization, exchange or similar event or otherwise; provided, however, that as to any Investor Share, such Investor Share shall cease to be a Registrable Investor Share when: (i) a Registration Statement (as
defined herein) covering such Registrable Investor Share has been declared effective and such Registrable Investor Share has been disposed of pursuant to such effective Registration Statement; (ii) such Registrable Investor Share shall have
been sold pursuant to Rule 144 (or any similar provision then in effect) under the Securities Act; (iii) such Registrable Investor Share is otherwise transferred in a private transaction and is no longer held by any Investor; or (iv) such
Registrable Investor Share ceases to be outstanding; 
 (fff)     “Registration Statement” means any
registration statement filed pursuant to the Securities Act; 
 (ggg)     “Requisite Approval” means
the consent of at least fifty-five percent (55%) of the voting power of the Investors; 
 (hhh)     “ROFR
Closing” has the meaning set forth in Section 8.2(c); 
 (iii)     “ROFR Holder”
means each of the Investors and any of its Affiliates and its permitted assignees to whom its rights under Section 8.2 have been duly assigned in accordance with this Agreement; 

(jjj)     “ROFR Notice” has the meaning set forth in Section 8.2(a); 

(kkk)     “ROFR Offer” has the meaning set forth in Section 8.2(b); 

  
 -6- 

 (lll)     “Round A Director” means any member of the
Board of Directors appointed by the Round A Investors; 
 (mmm)     “Round A Investor”, and
collectively, “Round A Investors”, have the meaning set forth in the Recitals; 
 (nnn)    
“Round A Shareholders Agreement” has the meaning set forth in the Recitals; 
 (ooo)     “Round
A and B Share Subscription Agreement” has the meaning set forth in the Recitals; 
 (ppp)     “Round B
Director” means any member of the Board of Directors appointed by the Round B Investors; 
 (qqq)    
“Round B Investor”, and collectively, “Round B Investors”, have the meaning set forth in the Recitals; 

(rrr)     “Round B Shareholders Agreement” has the meaning set forth in the Recitals; 

(sss)     “Round C Investor”, and collectively, “Round C Investors”, have the meaning
set forth in the Preamble; 
 (ttt)     “SEC” means the U.S. Securities and Exchange Commission; 

(uuu)     “Securities Act” means the U.S. Securities Act of 1933, as amended; 

(vvv)     “Series A Preferred Shares” has the meaning set forth in the Recitals; 

(www)     “Shares” means any of the issued and outstanding shares of all classes of share capital of the
Company; 
 (xxx)     “STCH” means STCH Investment Inc.; 

(yyy)     “Subsidiary”, and collectively, “Subsidiaries”, mean, with respect to any
Person, any and all corporations, partnerships, limited liability companies, joint ventures, associations, variable interest entities or other entities controlled by such Person directly or indirectly through one or more intermediaries; 

(zzz)     “Suspension Period” has the meaning set forth in Section 5.1(a); 

(aaaa)     “Tax” means all forms of taxation whether direct or indirect and whether levied by reference
to income, profits, gains, net wealth, asset values, turnover, added value or other reference and statutory, governmental, state, provincial, local governmental or municipal impositions, duties, contributions, rates and levies (including without
limitation social security contributions and any other payroll taxes), whenever and wherever imposed (whether imposed by way of a withholding or deduction for or on account of tax or otherwise) and in respect of any person and all penalties,
charges, costs and interest relating thereto; 

  
 -7- 

 (bbbb)     “Taxing Authority” means any taxing or other
authority competent to impose any liability in respect of Tax or responsible for the administration and/or collection of Tax or enforcement of any law in relation to Tax; 

(cccc)     “U.S. Dollars” or “US$” means United States dollars, the lawful currency of
the United States of America; and 
 (dddd)     “U.S. GAAP” means generally accepted accounting
principles in the United States as in effect from time to time. 
 1.2     Interpretation; Construction. 

(a)     The table of contents and headings herein are for convenience of reference only, do not constitute part of this
Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to an annex, exhibit or section, such reference shall be to an annex, exhibit or section to this Agreement
unless otherwise indicated. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. 

(b)     The Parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity
or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any
provision of this Agreement. 
 ARTICLE II. 

DEMAND REGISTRATION 

2.1     Right to Request Demand Registration. Subject to the provisions hereof, so long as an Affiliate Investor
continues to be an Affiliate of the Company, such Affiliate Investor may, upon the request of holders of at least twenty-five percent (25%) of the Registrable Shares, at any time commencing the earlier of: (i) one hundred eighty
(180) days after a Qualified IPO or (ii) the fifth (5th) anniversary of the Execution Date, request registration under the Securities Act, of all or part of the Registrable Investor Shares separate from an F-3 Registration (a
“Demand Registration”); provided, however, that the Company shall not be obligated to effect a Demand Registration if the Affiliate Investor and any Designated Holders that have requested the opportunity to include
Registrable Shares in the Demand Registration pursuant to this Agreement propose to sell Registrable Shares at an aggregate price (based on the then-current market prices) to the public of less than US$50,000,000. 

2.2     Effective Demand Registration. Subject to the provisions of this Article II and
Section 5.1, the Company shall use reasonable efforts to: (i) publicly file with the SEC, no more than one hundred twenty (120) days after receipt of an Affiliate Investor’s request pursuant to Section 2.1, a
Registration Statement registering, subject to Section 2.6, such number of Registrable Investor Shares as requested by any Affiliate Investor to be so registered pursuant to Section 2.1; and (ii) cause such Registration
Statement to be declared effective by the SEC as soon as practicable thereafter. 

  
 -8- 

 2.3     Number of Demand Registrations. Each Affiliate Investor
may request up to two (2) Demand Registrations. The Company shall not count a request for registration as a Demand Registration for purposes of this Section 2.3 unless and until the Registration Statement filed with the SEC pursuant
to such request has become effective or as otherwise specified in Section 2.6 or Section 5.1. 

2.4     Selection of Underwriters. The Company shall have the right to select the managing underwriter or
underwriters to administer any such offering. 
 2.5     Priority on Demand Registrations. If the managing
underwriters of the Demand Registration advise the Company and the Affiliate Investor that in their opinion the number of Shares proposed to be included in the Demand Registration exceeds the number of Shares that can be sold in such underwritten
offering without materially delaying or jeopardizing the success of the offering (including the price per Share of the Registrable Shares proposed to be sold in such underwritten offering) (the “Maximum Offering Size”), the Company
shall include in such Demand Registration the number of Registrable Shares requested to be included therein by the Affiliate Investor and the Designated Holders pro rata among all such Affiliate Investor and Designated Holders, such that the
aggregate number of Shares (including any Registrable Shares) proposed to be registered by the Company and all such holders does not exceed the Maximum Offering Size. 

2.6     Effective Period of Demand Registrations. The Company shall use reasonable efforts to keep any Demand
Registration continuously effective for a period equal to thirty (30) days from the date on which the Registration Statement is declared effective by the SEC or such shorter period that shall terminate when all of the Registrable Investor
Shares covered by such Demand Registration have been sold. If the Company shall withdraw any Demand Registration pursuant to Section 5.1 before the earlier of: (i) the date when such thirty (30) days end; and (ii) the date
when all of the Registrable Investor Shares covered by such Demand Registration have been sold pursuant thereto, the Affiliate Investor shall be entitled to a replacement Demand Registration, which shall be subject to all of the provisions of this
Agreement. 

  
 -9- 

 ARTICLE III. 

PIGGYBACK REGISTRATION 

3.1     Right to Request a Piggyback Registration. If the Company proposes to register any Shares under the
Securities Act (a “Piggyback Registration”) (other than on a Registration Statement on Form F-4, Form S-4, Form F-8 or Form S-8) at any time until the first date on which there are no Registrable Investor Shares outstanding, whether
for its own account or for the account of one or more holders of Shares (excluding any Demand Registration pursuant to Article II, which shall be governed exclusively by Article II, and any F-3 Registration pursuant to Article
IV, which shall be governed exclusively by Article IV), and the form of Registration Statement is suitable for the registration of Registrable Investor Shares, the Company shall give written notice to the Affiliate Investors at least ten
(10) days before the anticipated filing date of its intention to effect such a registration and, subject to Section 3.3, Section 3.4 and Section 3.5, shall include in such Registration Statement and in any
offering of Shares to be made pursuant to that Registration Statement such number of Registrable Investor Shares that the Affiliate Investor may request in writing to the Company to be included in the Registration Statement; provided that
such written request by an Affiliate Investor must be made no later than five (5) days after receipt by the Affiliate Investor of the notice and the Company shall have no obligation to proceed with any Piggyback Registration and may abandon,
terminate and/or withdraw the Piggyback Registration for any reason at any time prior to the pricing thereof. There shall be no limit on the number of times any Investor may request registration of Registrable Investor Shares under this
Section 3.1. 
 3.2     Selection of Underwriters. The Company shall have the right to select the
managing underwriter or underwriters to administer any underwritten offering pursuant to any Piggyback Registration. 

3.3     Priority on Primary Piggyback Registrations. If a Piggyback Registration is initiated as a primary
underwritten offering on behalf of the Company, and the managing underwriters advise the Company that in their opinion the number of Shares (including any Registrable Shares) proposed to be included in such Piggyback Registration exceeds the Maximum
Offering Size, the Company shall include in such Piggyback Registration: 
 (a)     first, such number of Shares the
Company proposes to include in the Piggyback Registration; and 
 (b)     second, to the extent the number of Shares
included in the Piggyback Registration under clause (a) is: 
 (i)     less than the Maximum
Offering Size, the number of Registrable Investor Shares requested to be included therein by the Affiliate Investor in an aggregate amount not to exceed the Maximum Offering Size less the Shares included under clause (i), such that the
sum of the Shares proposed under clause (a) plus the number of Registrable Investor Shares proposed to be registered under clause (b) does not exceed the Maximum Offering Size; and 

(ii)     greater than or equal to the Maximum Offering Size, the number of Registrable Investor Shares
requested to be included therein by the Affiliate Investor in an aggregate amount not to exceed the Maximum Offering Size. 

3.4     Priority on Secondary Piggyback Registrations. Subject to Section 3.3, if a Piggyback
Registration is initiated as a secondary underwritten registration on behalf of the holders of Shares, and the managing underwriters advise the Company that in their opinion the number of Shares (including any Registrable Shares) proposed to be
included in such Piggyback Registration exceeds the Maximum Offering Size, the Company shall include in such Piggyback Registration the number of Registrable Shares requested to be included therein by the Affiliate Investor and the Designated
Holders and the number of Shares requested, and agreed by the Company, to be included therein by the holders of Shares, pro rata among all such holders, such that the aggregate number of Shares (including any Registrable Shares) proposed to be
registered by the Company and all such holders does not exceed the Maximum Offering Size. 

  
 -10- 

 3.5     Basis of Participation. No Affiliate Investor may sell
Registrable Investor Shares in any offering pursuant to a Piggyback Registration unless it: (i) agrees to sell such Registrable Investor Shares on the same basis provided in the underwriting or other distribution arrangements approved by the
Company and that apply to the Company and/or any holders of Shares (including Registrable Shares) involved in such Piggyback Registration; and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting
agreements, lockups and other documents required under the terms of such arrangements. 
 ARTICLE IV. 

F-3 REGISTRATION 

4.1     Right to Request F-3 Registration. Subject to the provisions hereof and the eligibility of the Company to
use Form F-3, an Affiliate Investor may at any time commencing twelve (12) months after the Execution Date request that the Company file a Registration Statement on Form F-3 (or an amendment or supplement to an existing Registration Statement
on Form F-3) for a public offering of all or such portion of the Registrable Investor Shares owned and designated by such Affiliate Investor pursuant to Rule 415 promulgated under the Securities Act or otherwise (an “F-3
Registration”); provided, however, that the Company shall not be obligated to effect an F-3 Registration if the Affiliate Investor together with any Designated Holders that have requested the opportunity to include Registrable
Shares in the F-3 Registration pursuant to this Agreement propose to sell Registrable Shares at an aggregate price (based on the then-current market prices) to the public of less than US$15,000,000. 

4.2     Effective F-3 Registration. Subject to the provisions of this Article IV and
Section 5.1, the Company shall use reasonable efforts to: (i) publicly file with the SEC, no more than ninety (90) days after receipt of an Affiliate Investor’s request pursuant to Section 4.1, a Registration
Statement on Form F-3 registering, subject to Section 4.5, such number of Registrable Investor Shares as requested by the Affiliate Investor to be so registered pursuant to Section 4.1; and (ii) cause such Registration
Statement to be declared effective by the SEC as soon as practicable thereafter. If permitted under the Securities Act, such Registration Statement shall be one that is automatically effective upon filing. 

4.3     Number of F-3 Registrations. Except as otherwise provided herein, there shall be no limit on the number of
times that the Affiliate Investor may request an F-3 Registration, except that no more than one (1) F-3 Registration may be requested within any 12-month period. The Company shall not deem any registration requested by the Affiliate Investor
pursuant to Section 4.1 to be a Demand Registration for purposes of Section 2.3. 
 4.4    
Selection of Underwriters. The Company shall have the right to select the managing underwriter or underwriters to administer any such offering. 

  
 -11- 

 4.5     Priority on F-3 Registrations. If the managing
underwriters of the requested F-3 Registration advise the Company and the Affiliate Investor that in their opinion the number of Registrable Shares proposed to be included in the F-3 Registration exceeds the Maximum Offering Size, the Company shall
include in such F-3 Registration the number of Registrable Shares requested to be included therein by the Affiliate Investor and the Designated Holders pro rata among all such Affiliate Investor and Designated Holders, such that the aggregate number
of Shares (including any Registrable Shares) proposed to be registered by the Company and all such holders does not exceed the Maximum Offering Size. 

4.6     Effective Period of F-3 Registrations. The Company shall use reasonable efforts to keep any F-3
Registration effective until the earlier of: (i) the date that all of the Registrable Investor Shares covered by such F-3 Registration have been sold; and (ii) the date as of which the Affiliate Investor is permitted to sell its
Registrable Investor Shares without registration pursuant to Rule 144 under the Securities Act without volume limitations or other restrictions on transfer thereunder. 

ARTICLE V. 
 SUSPENSION
PERIOD 
 5.1     Suspension Period. 

(a)     The Company may (i) delay the filing or effectiveness of a Registration Statement in conjunction with a
Demand Registration or an F-3 Registration or (ii) prior to the pricing of any offering of Registrable Investor Shares pursuant to a Demand Registration or an F-3 Registration, delay such offering (and, if it so chooses, withdraw any
Registration Statement that has been filed) if any Founder, in consultation with the Board of Directors, determines in good faith (x) that proceeding with such an offering would require the Company to disclose material information that would
not otherwise be required to be disclosed at that time and that the disclosure of such information at that time would not be in the best interests of the Company or its shareholders or (y) that the registration or offering to be delayed would,
if not delayed, materially and adversely affect the Company, taken as a whole, or materially interfere with, or jeopardize the success of, any pending or proposed material transaction, including any debt or equity financing, any acquisition or
disposition, any recapitalization or reorganization or any other material transaction. Any period during which the Company has delayed a filing, an effective date or an offering pursuant to this Section 5.1(a) is herein called a
“Suspension Period”. 
 (b)     If pursuant to Section 5.1(a) the Company delays a Demand
Registration or withdraws a Registration Statement, as the case may be, requested by any Investor, then such Investor shall be entitled to withdraw such request and such request shall not count against the limitations on registrations set forth in
Section 2.3. The Company shall provide prompt written notice to such Investor of the commencement and termination of any Suspension Period and any withdrawal of a Registration Statement pursuant to Section 5.1(a). Such
Investor shall keep the existence of each Suspension Period confidential and refrain from making offers and sales of Registrable Investor Shares during each Suspension Period. In no event shall: (i) the Company deliver notice of a Suspension
Period to any Investor more than three times in any 12-month period; or (ii) a Suspension Period or Suspension Periods be in effect for ninety (90) consecutive days or more in any 12-month period. 

  
 -12- 

 5.2     Additional Registration Rights. The Company agrees not to
grant registration or offering rights senior to those granted to the Affiliate Investors to any other holder of the Company’s securities without the prior approval of a majority of the Affiliate Investors. 

ARTICLE VI. 

REGISTRATION EXPENSES 

6.1     Registration Expenses. The Company shall bear all expenses incident to the Company’s performance of or
compliance with this Agreement, including without limitation (i) all registration and filing fees, (ii) fees and expenses of compliance with securities Laws, (iii) printing expenses, (iv) fees and disbursements of counsel for the
Company, (v) all independent certified public accountants and other Persons retained by the Company and (vi) all “road show” expenses incurred in respect of any underwritten offering, including all costs of travel, lodging and
meals (such expenses, the “Registration Expenses”). Each Investor participating in a registration shall bear such Investor’s proportionate share (based on the total number of shares sold in such registration other than for the
account of the Company) of all underwriting discounts and commissions associated with any sale of Registrable Investor Shares and shall pay all of its own costs and expenses, including all fees and expenses of any counsel (and any other advisers)
representing it, any share transfer taxes and duties, and ADS conversion fees, if any. 
 6.2     Termination of
Registration Rights. Notwithstanding anything to the contrary in this Agreement, the Company’s obligations under Article II through VI (inclusive) with respect to any Affiliate Investor, shall automatically terminate at the
date on which, in the opinion of counsel to the Company, all Registrable Investor Shares may be sold without registration and without regard to any volume limitation requirement pursuant to Rule 144 promulgated under the Securities Act. 

ARTICLE VII. 

MANAGEMENT AND INFORMATION RIGHTS 

7.1     Delivery of Financial Statements. The Company covenants and agrees that, commencing on the date of this
Agreement, for so long as any Investor holds any shares of the Company, the Company shall deliver to each Investor, provided that the Board of Directors has not reasonably determined that such Investor is a Competitor of the Company: 

(a)     as soon as practicable, but in any event within one hundred twenty (120) days after the end of each fiscal
year of the Company (i) a balance sheet as of the end of such year, (ii) an income statement for such year, and (iii) a statement of cash flows for such year, all such financial statements prepared in accordance with U.S. GAAP or
IFRS, audited and certified by independent public accountants of a Big 4 Accounting Firm selected by the Company; 

  
 -13- 

 (b)    as soon as practicable, but in any event within forty-five
(45) days after the end of each fiscal quarters of the Company (i) an unaudited balance sheet as of the end of such quarter, (ii) an unaudited income statement for such quarter, and (iii) an unaudited statement of cash flows for
such quarter prepared in accordance with U.S. GAAP or IFRS; and 
 (c)    as soon as practicable, but in any event
within ten (10) days after the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”), approved by the Board of Directors, including balance sheets, income statements and
statements of cash flow and, promptly after prepared, any other budgets or revised budgets prepared by the Company and approved by the Board of Directors. 

If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period,
the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything else in this Section 7.1 to the contrary, the Company may cease providing the information set forth in this
Section 7.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a Registration Statement if it reasonably concludes it must do so to comply with the SEC rules
applicable to such Registration Statement and related offering; provided that the Company’s covenants under this Section 7.1 shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable
efforts to cause such Registration Statement to become effective. 
 7.2    Inspection Rights. The Company shall
permit each Affiliate Investor to (a) visit and inspect the headquarter of the Company and (b) discuss the business, affairs, finances and accounts of the Group with officers of the Company, in each case during normal business hours and in
such a manner so as not to unreasonably interfere with the normal operations of the Group Companies, provided that each Affiliate Investor shall not exercise such rights more than twice a year. 

7.3    Termination of Information Rights. The covenants set forth in Section 7.1 and Section 7.2 shall
terminate and be of no further force or effect (i) immediately before the consummation of a Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange
Act, or (iii) upon the closing of a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and
Articles., whichever event occurs first. 
 7.4    Confidentiality. Each Investor agrees that such Investor will
keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the
Company’s intention to file a Registration Statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 7.4 by such Investor),
(b) is or has been independently developed or conceived by such Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to such Investor by a third party without a breach of any
obligation of confidentiality such third party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the
extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the
provisions of this Section 7.4; (iii) to any Affiliate, partner, member, shareholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such
information is confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, regulation, rule, court order or subpoena, provided that such Investor promptly
notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. 

  
 -14- 

 ARTICLE VIII. 

RIGHTS AND RESTRICTIONS REGARDING SHARE TRANSFERS 

8.1    Right of First Offer. Subject to the terms and conditions of this Section 8.1 and applicable
securities Laws, if the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to the Investors. Each Investor shall be entitled to apportion the right of first offer hereby granted to it in such
proportions as it deems appropriate, among (i) itself, (ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person having “beneficial ownership”, as such term is
defined in Rule 13d-3 promulgated under the Exchange Act, of the Investor (“Investor Beneficial Owners”); provided that each such Affiliate or Investor Beneficial Owner (x) is not a Competitor, unless such party’s
purchase of New Securities is otherwise consented to by the Board of Directors, (y) agrees to enter into this Agreement as an “Investor” under such agreement (provided that any Competitor as reasonably determined by the Board
of Directors shall not be entitled to any rights under Sections 7.1, 7.2 and 8.1 hereof), and (z) agrees to purchase at least such number of New Securities as are allocable hereunder to the Investor holding the fewest
number of Investor Shares and any other Derivative Securities. 
 (a)    The Company shall give notice (the
“Offer Notice”) to each Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes
to offer such New Securities. 
 (b)    By notification to the Company within thirty (30) days
after the Offer Notice is given, each Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Ordinary Shares
then held by such Investor (including all Ordinary Shares then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Series A Preferred Shares and any other Derivative Securities then held by such Investor) bears
to the total Ordinary Shares of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Series A Preferred Shares and any other Derivative Securities then outstanding). At the expiration of such 30-day period,
the Company shall promptly notify each Investor that elects to purchase or acquire all the shares available to it (each, a “Fully Exercising Investor”) of any other Investor’s failure to do likewise. During the 10-day period
commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of shares specified above, up to that portion of the New Securities for
which the Investors were entitled to subscribe but that were not subscribed for by the Investors which is equal to the proportion that the Ordinary Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as
applicable, of Series A Preferred Shares and any other Derivative Securities then held, by such Fully Exercising Investor bears to the Ordinary Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as
applicable, of the Series A Preferred Shares and any other Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Section 8.1(b) shall
occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Section 8.1(c). 

  
 -15- 

 (c)    If all New Securities referred to in the Offer
Notice are not elected to be purchased or acquired as provided in Section 8.1(b), the Company may, during the 90-day period following the expiration of the periods provided in Section 8.1(b), offer and sell the remaining
unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of
the New Securities within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless
first reoffered to the Investors in accordance with this Section 8.1. 
 (d)    The right of first offer in
this Section 8.1 shall not be applicable to (i) Exempted Securities (as defined in the Company’s Constitutive Documents), (ii) Ordinary Shares issued in an initial public offering and (iii) equity securities of the
Company issued under the Employee Share Option Plan. 
 8.2    Right of First Refusal. 

(a)    Notice of Offer. If any holder of Shares (the “Proposed ROFR Seller”) intends to sell all or
any part of the Shares it owns pursuant to a bona fide offer to buy from a Person (the “Proposed ROFR Purchaser”), the Proposed ROFR Seller shall submit a written notice (the “ROFR Notice”) to the Company and the
Investors stating the name of the Proposed ROFR Purchaser, the number of Shares proposed to be sold (the “Offered Shares”), the material terms and conditions, including price, of the proposed sale. The Company shall have fifteen
(15) Business Days from the date of the Proposed ROFR Seller issues the ROFR Notice, which shall be irrevocable for such time, to provide a written offer to the Proposed ROFR Seller to purchase all or any portion of the Offered Shares on terms,
including price, no less favorable to the Proposed ROFR Seller than those reflected in the ROFR Notice. 

(b)    Exercise of Right of First Refusal. If the Company has not elected to purchase all of the Offered Shares,
the Company shall inform the Investors, within fifteen (15) Business Days after the ROFR Notice has been delivered to the Company, in writing of the number of Offered Shares that it has elected not to purchase, and each Investor that has
received such notice from the Company shall have forty-five (45) Business Days from the date the Proposed ROFR Seller issues the ROFR Notice (the “ROFR Holders’ First Refusal Period”), which shall be irrevocable for such
time, to provide a written offer to the Company and the Proposed ROFR Seller to purchase all or part of the remaining of the Offered Shares on terms, including price, no less favorable to the Proposed ROFR Seller than those reflected in the ROFR
Notice (the “ROFR Offer”). Any ROFR Offer shall be irrevocable by the offering Investor and shall constitute a binding agreement. Each ROFR Holder shall have the right to purchase that number of the Offered Shares, equivalent to the
product obtained by multiplying the aggregate number of the Offered Shares, by a fraction, the numerator of which is the number of Ordinary Shares (on an as-converted basis) held by such ROFR Holder at the time of the transaction and the denominator
of which is the total number of Ordinary Shares (on an as-converted basis) owned by all ROFR Holders at the time of the transaction who have the right of first refusal to purchase the applicable shares and have elected to participate in such right
of first refusal purchase. 

  
 -16- 

 (c)    Closing. The closing of any purchase of shares of the
Company by a ROFR Holder pursuant to this Section 8.2(c) (the “ROFR Closing”) shall occur on such date as may be agreed by such ROFR Holder and the Proposed ROFR Seller, but in no event later than seventy-five
(75) Business Days after the date on which the ROFR Notice is deemed to have been accepted. At the ROFR Closing, if all necessary conditions of the ROFR Closing have been satisfied or waived: (i) the Proposed ROFR Seller shall deliver to
such ROFR Holder (x) an instrument of transfer executed by the Proposed ROFR Seller in favor of the ROFR Holder and (y) either an extract of the register of shareholders of the Company, dated as of the date of the ROFR Closing and duly
certified by the registered office provider of the Company, evidencing the ROFR Holder’s ownership of the Offered Shares set out in the ROFR Offer or a certificate or certificates representing the Offered Shares; and (ii) the ROFR Holder
shall deliver to the Proposed ROFR Seller the purchase price for the Offered Shares in cash, by wire transfer of immediately available funds to an account designated by the Proposed ROFR Seller, such account to be designated by the Proposed ROFR
Seller no later than five (5) Business Days prior to the ROFR Closing. 
 (d)    Expiration Notice. Within
ten (10) days following the expiration of the ROFR Holders’ First Refusal Period, the Company will give written notice (the “First Refusal Expiration Notice”) to the Proposed ROFR Seller and the ROFR Holders specifying
either (i) that all of the Offered Shares were subscribed by the ROFR Holders exercising their rights of first refusal, or (ii) that the ROFR Holders have not subscribed for any or all of the Offered Shares in which case the First Refusal
Expiration Notice will specify the Co-Sale Pro Rata Portion (as defined below) of the remaining Offered Shares (the “Remaining Shares”) for the purpose of the co-sale right of the Investors described in the Section 8.3
below. 
 (e)    Exclusions. Notwithstanding Section 8.2(a), none of the following transactions shall
be subject to the right of first refusal described in this Section 8.2: (i) any transfer of Shares by a Founder or an Investor to any Affiliate of such Founder or such Investor; (ii) any sale in reliance on Rule 144A under the
Securities Act; (iii) any sale of shares of the Company pursuant to Rule 144 under the Securities Act; (iv) any sale of shares of the Company to the public pursuant to a Registration Statement filed with, and declared effective by, the SEC
under the Securities Act; and (v) other on-market sales; provided that in each of (ii) and (iv) above, any such sale shall be (x) to five (5) or more purchasers, none of which shall be Affiliates of any other such
purchaser and (y) no more than five percent (5%) of the total number of issued and outstanding Shares on a fully diluted basis shall be transferred by any seller in any such sale or series of such sales to any purchaser in aggregate with
its Affiliates. 

  
 -17- 

 (f)    Subordination. The Investors’ right of first refusal
under this Section 8.2 shall be subordinated to only the Company’s right of first refusal. 

8.3    Co-Sale Right. In the event that any Founder of any Founder Holding Company proposes to sell any or all of
the number of Shares (the “Founders’ Offered Shares”), then the Remaining Shares shall be subject to co-sale rights under this Section 8.3 and each ROFR Holder who has not exercised any of its right of first refusal with respect
to the Founders’ Offered Shares (the “Co-Sale Right Holder”) shall have the right, exercisable upon written notice to the Proposed ROFR Seller, the Company and each other Co-Sale Right Holder (the “Co-Sale Notice”) within
ten (10) Business Days after receipt of First Refusal Expiration Notice (the “Co-Sale Right Period”), to participate in such sale of the Remaining Shares on the same terms and conditions as set forth in the ROFR Notice. The Co-Sale
Notice shall set forth the number of Ordinary Shares that such Co-Sale Right Holder wishes to include in such sale or transfer, which amount shall not exceed the Co-Sale Pro Rata Portion (as defined below) of such Co-Sale Right Holder. To the extent
one or more of the Co-Sale Right Holders exercise such right of participation in accordance with the terms and conditions set forth below, the number of Ordinary Shares that such Proposed ROFR Seller may sell in the transaction shall be
correspondingly reduced. The co-sale right of each Co-Sale Right Holder shall be subject to the following terms and conditions: 

(a)    Co-Sale Pro Rata Portion. Each Co-Sale Right Holder may sell all or any part of that number of Ordinary
Shares (on an as-converted basis) held by it that is equal to the product obtained by multiplying (x) the aggregate number of the Remaining Shares subject to the co-sale right hereunder by (y) a fraction, the numerator of which is the
number of Ordinary Shares (on an as-converted basis) owned by such Co-Sale Right Holder at the time of the sale or transfer and the denominator of which is the combined number of Ordinary Shares (on an as-converted basis) at the time owned by all
Co-Sale Right Holders who elect to exercise their co-sale rights (if any Co-Sale Right Holder does not elect to exercise the co-sale right to the full extent then its Ordinary Shares (on as-converted basis) for calculation in the denominator shall
be proportionately reduced) (“Co-Sale Pro Rata Portion”). 
 (b)    Transferred Shares. Each
participating Co-Sale Right Holder shall effect its participation in the sale by promptly delivering to the Proposed ROFR Seller for transfer to the Proposed ROFR Purchaser an executed instrument of transfer and one or more certificates which
represent: 
 (i)    the number of Ordinary Shares (on an as-converted basis) which such Co-Sale Right
Holder elects to sell; 
 (ii)    that number of Preferred Shares which is at such time convertible into
the number of Ordinary Shares that such Co-Sale Right Holder elects to sell; provided in such case that, if the Proposed ROFR Purchaser objects to the allotment of Preferred Shares in lieu of Ordinary Shares, such Co-Sale Right Holder shall
convert such Preferred Shares into Ordinary Shares and allot Ordinary Shares as provided in Subsection 8.3(b)(i) above. The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the purchaser; or

  
 -18- 

 (iii)    a combination of the above. 

(c)    Payment. The share certificate or certificates, together with an instrument of transfer duly executed by the
participating Co-Sale Right Holder, that the participating Co-Sale Right Holder delivers to the Proposed ROFR Seller pursuant to Section 8.3(b) shall be transferred to the Proposed ROFR Purchaser in consummation of the sale of the
Founders’ Offered Shares pursuant to the terms and conditions specified in the ROFR Notice, and the Proposed ROFR Seller shall concurrently therewith remit to such Co-Sale Right Holder that portion of the sale proceeds to which such Co-Sale
Right Holder is entitled by reason of its participation in such sale. To the extent that any Proposed ROFR Purchaser prohibits such assignment or otherwise refuses to purchase any shares or other securities from a Co-Sale Right Holder exercising its
co-sale right hereunder, the Proposed ROFR Seller shall not sell to such Proposed ROFR Purchaser any ROFR Shares unless and until, simultaneously with such sale, the Proposed ROFR Seller shall purchase such shares or other securities from such
Co-Sale Right Holder. 
 (d)    Right to Transfer. To the extent the ROFR Holders do not elect to purchase, or to
participate in the sale of, any or all of the Founders ‘Offered Shares subject to the ROFR Notice, the Proposed ROFR Seller may, not later than ninety (90) Business Days following delivery to the Company and each of the ROFR Holders of the
ROFR Notice, conclude a transfer of the Remaining Shares covered by the ROFR Notice and not elected to be purchased by the ROFR Holders, which in each case shall be on substantially the same terms and conditions as those described in the ROFR
Notice. The Proposed ROFR Seller shall cause any Proposed ROFR Purchaser of such shares to comply with this Agreement and Memorandum and Articles, as maybe amended from time to time, to the fullest extent. Any proposed transfer on terms and
conditions which are materially different from those described in the ROFR Notice, as well as any subsequent proposed transfer of any ROFR Shares by the Proposed ROFR Seller, shall again be subject to the right of first refusal of the ROFR Holders
and the co-sale right of the Co-Sale Right Holders and shall require compliance by the Proposed ROFR Seller with the procedures described in Sections 8.2 and 8.3 of this Agreement. 

8.4    Prohibited Transfers 

(a)    Subject to Section 8.6, none of the Founder Holding Companies shall sell, assign, transfer, pledge,
hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions, directly or indirectly any Ordinary Shares held by it to any Person on or prior to a Qualified IPO. Any attempt by the Founder Holding Companies to sell or
transfer Ordinary Shares in violation of this Section 8.4 shall be void, and the Company hereby agrees that it will not effect such a transfer nor will it treat any alleged transferee as the holder of such shares. 

  
 -19- 

 (b)    The Founders and the Founder Holding Companies agree that the
restrictions with regard to the transfer of the Founder Holding Companies’ shares in the Company as described under this Section 8.4 shall apply equally to transfer of the shares of the Founder Holding Companies, as if each of the
provisions under this Section 8.4 has been repeated with regard to transfer of the shares of the Founder Holding Companies except that the reference to the shares in the Company has been revised to refer to the shares in the Founder Holding
Companies, as applicable, so that the result of such restrictions on the indirect transfer of the shares in the Company by transferring the shares in the Founder Holding Companies is the same as if the Founder Holding Companies directly transfer the
relevant shares in the Company. 
 8.5    Restrictions on Issuance by Group Company Prior to a Qualified IPO, the
Founders shall not cause any Group Company (other than the Company) to, issue to any Person any equity securities of such Group Company, or any options or warrants for, or any other securities exchangeable for or convertible into, such equity
securities of such Group Company. 
 8.6    Founder Transfers. Notwithstanding anything to the contrary in this
Agreement, the Founders or the Founder Holding Companies may sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions, directly or indirectly no more than five percent (5%) of
the outstanding Shares accumulatively to any party so long as the Founder collectively beneficially own more than fifty percent (50%) of the outstanding Shares following such transfer. 

8.7    Termination of Rights and Restrictions. The covenants set forth in this Article VIII shall terminate
and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or
(iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and Articles., whichever
event occurs first. 
 ARTICLE IX. 

DRAG-ALONG OBLIGATION 

9.1    Drag-Along Rights. 

(a)    If, at any time prior to a Qualified IPO, any Investor (the “Drag-Along Seller”) secures an
irrevocable offer to acquire all share capital or assets of the Company (a “Drag-Along Sale”) with a valuation of the Company of more than US$600,000,000 with any Person (such Person, a “Drag-Along Purchaser”) upon
such terms and conditions as agreed to with the Drag-Along Seller, and such Drag-Along Sale is agreed by a majority vote of the other Investors and a majority vote of the Founders, each other Investor (an “Other Investor”) agrees,
at the request of the Drag-Along Seller, to participate in such Drag-Along Sale as set forth in this Section 9.1. 

  
 -20- 

 (b)    If the Drag-Along Sale is structured as a sale of Shares, each
Other Investor shall sell to the Drag-Along Purchaser all Shares then held by such Other Investor on the same terms and conditions as are applicable to the Drag-Along Seller, including the same per-share consideration with respect to a specific
class of Shares, and shall execute the necessary transfer forms in favor of the Drag-Along Purchaser; provided that the proceeds from such sale of any Round C Investors shall not be less than the higher of (i) the Series A Liquidation
Amount (as defined in the Memorandum and Articles) or (ii) the purchase price as stated in the offer of the Drag-Along Purchaser pro rata based on the number of Ordinary Shares held by such Round C Investors (on an as-converted basis);
provided, further, that except with respect to any liability incurred by such Other Investor individually, such Other Investor shall not be liable to a Drag-Along Purchaser for an amount greater than the proceeds from such sale. 

(c)    If the Drag-Along Sale is structured as a merger, amalgamation or scheme of arrangement of the Company or other
transaction that requires the approval of the Investors, each Investor shall vote its respective Shares (or execute and deliver any written consents in lieu thereof) in favor of any Drag-Along Sale and all actions deemed reasonably necessary by the
Drag-Along Seller in connection with the Drag-Along Sale, and against any action or proposal that may prevent, hinder or impede the consummation of the Drag-Along Sale. 

(d)    The Drag-Along Seller shall provide written notice of a proposed Drag-Along Sale to the Other Investors (a
“Drag-Along Sale Notice”) not later than ten (10) days prior to such proposed Drag-Along Sale. The Drag-Along Sale Notice shall identify the Drag-Along Purchaser, the per-Ordinary Share consideration for which a transfer is
proposed to be made (the “Drag-Along Sale Price”) and all other material terms and conditions of the Drag-Along Sale. Each Other Investor shall be required to participate in the Drag-Along Sale on the terms and conditions set forth
in the Drag-Along Sale Notice and to tender its Shares. The price and form of consideration payable in such transfer shall be the Drag-Along Sale Price. 

(e)    The Drag-Along Seller shall have a period of 180 days from the date of receipt of the Drag-Along Sale Notice to
enter into a definitive agreement providing for the Drag-Along Sale on the terms and conditions set forth in such Drag-Along Sale Notice, which Drag-Along Sale shall be promptly consummated, subject to fulfilling any closing conditions and obtaining
any required regulatory approvals. If the Drag-Along Seller has not entered into a definitive agreement providing for the Drag-Along Sale within such 180-day period and the Drag-Along Seller proposes to effect a Drag-Along Sale after such 180-day
period, the Drag-Along Seller shall again comply with the procedures set forth in this Section 9.1(e). 

(f)    In connection with a Drag-Along Sale, each Other Investor shall (i) make such representations, warranties and
covenants and enter into such definitive agreements as are customary for transactions of the nature of the Drag-Along Sale, (ii) benefit from and be subject to all of the same provisions of the definitive agreements as are applicable to the
Drag-Along Seller, (iii) be required to bear its proportionate share of any escrows, holdbacks or adjustments in respect of the purchase price or indemnification obligations; provided that an Other Investor shall only be obligated to
indemnify any other Person in connection with such Drag-Along Sale severally; provided, further, that no Other Investor shall be obligated to indemnify any other shareholder for any breach or misrepresentation by such other shareholder
with respect to title in such other shareholder’s equity securities, (iv) be required to bear its proportionate share of the costs and expenses incurred by the Company and the Investors in connection with the proposed transaction (whether
or not consummated), including all attorney’s fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions (including, if requested by the Drag-Along Seller, an investment
banking firm selected by the Drag-Along Seller and engaged, on customary terms (including customary indemnification from the Company)), to the extent not paid by the Company, and (v) to the extent permitted by applicable Law, not exercise any
dissenters’ or appraisal rights to which they may be entitled in connection with a Drag-Along Sale. 

  
 -21- 

 9.2    Termination of Drag-Along Rights. The covenants set forth
in Section 9.1 shall terminate and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of
Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as
provided in the Memorandum and Articles., whichever event occurs first. 
 ARTICLE X. 

GOVERNANCE AND ADDITIONAL COVENANTS 

10.1    Board of Directors. 

(a)    As of the Execution Date, the Board of Directors shall consist of the following members: 

 

	 	(i)	 the Chief Executive Officer of the Company; 

 

	 	(ii)	 the Chief Operating Officer of the Company; 

 

	 	(iii)	 one (1) director appointed by the Chief Executive Officer of the Company; 

 

	 	(iv)	 one (1) Round A Director; 

 

	 	(v)	 one (1) Round B Director; and 

 

	 	(vi)	 one (1) Preferred Share Director 

(b)    Each of the Founders and the Affiliate Investors shall take all actions available to it in its capacity as a
shareholder of the Company, to take or cause to be taken all actions available to each that are necessary to maintain the composition of the Board of Directors as set forth in Section 10.1(a). 

(c)    Only the Party who had the power to designate a director pursuant to Section 10.1(a) shall have the
power to remove such director. Each of the Parties hereto agrees to take such action as is necessary to call a special meeting of the shareholders of the Company (or effect a written consent in lieu thereof) for the purpose of effecting any such
removal, and at such meeting each such Party shall vote to accomplish said result. In the event that any director is removed or shall have resigned or become unable to serve, the Party who had the power to designate such director pursuant to
Section 10.1(a) shall have the power to designate a person reasonably qualified to serve on the Board of Directors to fill such vacancy, whereupon each of the Parties hereto, or their successors and assigns, agree to take such action as
is necessary to promptly elect such person to fill such vacancy (including, if necessary, calling a special meeting of the shareholders of the Company (or effect a written consent in lieu thereof) and voting all shares owned by the Parties hereto to
accomplish such result). Except as provided above, no Party shall vote in favor of, or otherwise take any actions in respect of, the removal of any director who shall have been designated or nominated pursuant to Section 10.1(a). 

  
 -22- 

 (d)    The Board of Directors shall have a Chairman, and each of the
Founders and the Affiliate Investors shall cause its designee directors(s) to support resolutions and actions by written consent of the Board of Directors that maintain or appoint to the position of Chairman of the Board of Directors the Chief
Executive Officer of the Company. 
 (e)    On all actions to be taken and matters to be decided by the Board of
Directors, each director shall be entitled to cast one (1) vote, and subject to Section 10.3, the affirmative vote of the directors having a majority of the total voting power represented at a meeting at which a quorum is present
shall constitute an act of the Board of Directors. In the case of an equality of votes, the Chairman, if any, or in the absence of the Chairman, a director designated by the Board of Directors to preside at a meeting of the Board of Directors, shall
have a second or casting vote in addition to any other vote such person may have. 
 10.2    Matters Requiring
Requisite Approval. Each of the Company and the Founders hereby covenants and agrees with each of the Investors that no Group Companies shall take and Founders shall cause each Group Company not to take any of the following actions or effect or
agree or commit to do any of the following, in each case directly or indirectly, whether by merger, consolidation, amalgamation or otherwise without Requisite Approval: 

(a)    any change in any of the rights, preferences, privileges or priority of the holders of the Series A Preferred
Shares; 
 (b)    authorization, creation or issuance of any class or series of Shares having any right, preference or
priority superior to or on a parity with the Series A Preferred Shares; 
 (c)    repurchase or redemption of Shares
(other than pursuant to the Company’s Employee Share Option Plan); 
 (d)    amendment of any Group Company’s
memorandum and articles of association; 
 (e)    merger or consolidation of any Group Company; 

(f)    liquidation or dissolution of any of the Group Companies, as well as any Deemed Liquidation Event; and 

(g)    the sale, pledge or other disposition of all or substantially all of the Group Companies’ assets or the
purchase of all or substantially all of the assets of another entity. 

  
 -23- 

 10.3    Matters Requiring Approval of the Board of Directors.

 (a)    Each of the Company and the Founders hereby covenants and agrees with each of the Investors that no Group
Company shall take and Founders shall cause each Group Company not to take any of the following actions or effect or agree or commit to do any of the following, in each case directly or indirectly, whether by merger, consolidation, amalgamation or
otherwise without approval of a majority of the Board of Directors, including the affirmative vote of at least two (2) Investor Directors: 
  

	 	(i)	 the declaration or payment of a dividend on any shares/equity of the Group Companies; 

 

	 	(ii)	 the adoption or amendment of any employee share award plan, including the amendment of the Employee Share
Option Plan; 

  

	 	(iii)	 any material transaction between any Group Company and any of its shareholders, directors, officers, employees
or other insiders and any of their family members or affiliates other than on an arm’s-length basis and upon full disclosure to shareholders including the Investors; 

 

	 	(iv)	 the appointment or removal of the Chief Executive Officer of the Company; 

 

	 	(v)	 any incurrence of debt by any Group Company other than trade debts not exceeding US$10,000,000 in aggregate;

  

	 	(vi)	 adoption of the annual Budget; 

 

	 	(vii)	 appoint or change the auditors of the Company; 

 

	 	(viii)	 the license or transfer of any patents, copyrights, trademarks or other intellectual property rights outside
the normal business operations; 

  

	 	(ix)	 the termination or substantial change of the Company’s main business, or the involvement in any new
business that is significantly different from the current main business; 

  

	 	(x)	 the settlement of any material legal action with a value in access of RMB10,000,000; 

 

	 	(xi)	 any initial public offering plan other than a Qualified IPO; 

 

	 	(xii)	 any increase or decrease to the capital of any of the Group Companies; 

 

	 	(xiii)	 any pledge on material assets of any of the Group Companies; 

 

	 	(xiv)	 any change to the number of directors on the Board of Directors, any change to the rules governing election to
the Board of Directors and any change to the term of service of members of the Board of Directors; 

  
 -24- 

	 	(xv)	 any change to the name of the Company; 

 

	 	(xvi)	 any change to the Control Agreements (as defined in the Series A Share Purchase Agreement) and entering into
any new control agreement by any Group Company; 

  

	 	(xvii)	 any change to the voting rights of any shares of the Company; 

 

	 	(xviii)	 the establishment or cessation of any material business lines carried on by the Company; and

  

	 	(xix)	 any issuance to any Person any equity securities of the Company, or any options or warrants for, or any other
securities exchangeable for or convertible into, such equity securities of the Company, except for any issuance pursuant to (x) the Series A Share Purchase Agreement or Round A and B Share Subscription Agreement, (y) the Company’s
Employee Share Option Plan, or (z) the initial public offering. 

 (b)    Each of the Investors
and Founder Holding Companies hereby covenants and agrees that it shall not undertake any pledge over its Shares without approval of a two-thirds majority of the Board of Directors. 

10.4    Insurance. The Company shall obtain, upon the completion of a Qualified IPO, from financially sound and
reputable insurers, directors and officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts to cause such insurance policy to be maintained until such
time as the Board of Directors (including the affirmative votes by at least two (2) Investor Directors) determines that such insurance should be discontinued. 

10.5    Termination of Covenants. The rights and covenants set forth in this Article X (but with respect to
Section 10.4) shall terminate and be of no further force or effect (i) immediately before the consummation of a Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of
Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as
provided in the Memorandum and Articles., whichever event occurs first. 
 ARTICLE XI. 

CONFIDENTIALITY 
  

	 	11.1	 Confidentiality. 

 

	 	(a)	 Subject to Section 11.1(b): 

 

	 	(i)	 each of the Parties shall treat as strictly confidential and not disclose or use any documents, materials and
other information, in whatever form, whether technical or commercial, received or obtained by it prior to entering into this Agreement or as a result of entering into this Agreement, in each case which relates to: 

 

	 	(A)	 the provisions of this Agreement and any agreement entered into in relation to this Agreement; or

  

	 	(B)	 the negotiations relating to this Agreement (and any other agreements entered into in relation to this
Agreement); 

  
 -25- 

	 	(ii)	 each Party shall treat as strictly confidential and not disclose or use any information relating to the
business, financial or other affairs (including future plans and targets) of any other Party or any member of their group; 

  

	 	(iii)	 each Party shall treat as strictly confidential and not disclose or use any information relating to the
business, financial or other affairs (including future plans and targets) of the Company. 

(b)    Section 11.1(a) shall not prohibit disclosure or use of any information if and to the extent: 

 

	 	(i)	 the disclosure or use is required by law, any regulatory body or any recognized stock exchange on which the
shares of any Party are listed; 

  

	 	(ii)	 the disclosure or use is required to vest the full benefit of this Agreement in any Party;

  

	 	(iii)	 the disclosure or use is required for the purpose of any judicial proceedings arising out of this Agreement or
any other agreement entered into under or pursuant to this Agreement or the disclosure is made to a Taxing Authority in connection with the Tax affairs of the disclosing Party; 

 

	 	(iv)	 the disclosure is made to professional advisers or actual or potential financiers of any Party on a
need-to-know basis and on terms that these professional advisers or actual or potential financiers undertake to comply with the provisions of Section 11.1(a) in respect of such information as if they were a party to this Agreement;

  

	 	(v)	 the information is or becomes publicly available (other than by breach of this Agreement);

  

	 	(vi)	 the disclosure is made on a confidential basis to potential purchasers of all or part of any Party or to their
professional advisers or financiers; provided that any of these persons need to know the information for the purposes of considering, evaluating, advising on or furthering the potential purchase; 

  
 -26- 

	 	(vii)	 the other Party has given prior written approval, such approval not to be unreasonably withheld or delayed, to
the disclosure or use (including, without limitation, disclosure or use for the purposes of publicizing the transactions the subject of this Agreement or any other document drafted in connection with a Qualified IPO); or 

 

	 	(viii)	 the information is independently developed after the closing of the Qualified IPO; 

provided that, prior to disclosure or use of any information pursuant to Section 11.1(b)(i), (ii) or (iii), the Party
concerned shall promptly notify the other Parties of these requirements with a view to providing the other Parties with the opportunity to contest such disclosure or use or otherwise to agree on the timing and content of such disclosure or use. 

(c)    A recipient of confidential information may disclose such confidential information to its shareholders, employees,
directors, representatives and agents only to the extent reasonably necessary for the achievement of the objectives of this Agreement and the other documents drafted in connection with a Qualified IPO. A recipient of information shall ensure that
its relevant shareholders, employees, directors, representatives and agents are aware of and comply with the confidentiality obligations set out in this Article XI. 

11.2    Damages Not an Adequate Remedy. Without prejudice to any other rights or remedies which a Party may have,
the Parties acknowledge and agree that damages would not be an adequate remedy for any breach of this Article XI and the remedies of injunction, specific performance and other equitable relief are appropriate for any threatened or actual
breach of this provision and no proof of special damages shall be necessary for the enforcement of the rights under this Article XI. 

11.3    Survival. 

(a)    The disclosing Party shall remain responsible for any breach of this Article XI by the person to whom that
confidential information is disclosed. 
 (b)    The provisions of this Article XI shall survive the termination
of this Agreement for whatever cause. 
 ARTICLE XII. 

NON-COMPETITION; NON-SOLICITATION 
  

	 	12.1	 Non-Competition. 

 

	 	(a)	 Until the third (3rd) anniversary of the Execution Date, 

 

	 	(i)	 no Founder or Founder Holding Company shall, directly or indirectly, conduct, manage, invest in, control or own
any Competitor, unless such Founder or Founder Holding Company has first obtained the consent of a majority of the Investor Directors; and 

  
 -27- 

	 	(ii)	 each Founder and Founder Holding Company shall cause each of the directors and members of the senior management
of the Company to comply with the obligations of Section 12.1(a)(i); 

(b)    provided that the provisions of this Section 12.1 shall not prohibit the acquisition of any
Founder Holding Company by any Competitor as long as no employee of the Founder Holding Company becomes actively engaged in the management or operation of such Competitor; provided, further, that the foregoing shall not limit the
ability of the Founders, Founder Holding Companies and their respective Affiliates to engage in activities expressly contemplated by this Agreement. 

(c)    If a judicial or arbitral determination is made that any of the provisions of this Section 12.1
constitutes an unreasonable or otherwise unenforceable restriction against any Founder, the provisions of this Section 12.1 shall be rendered void only to the extent that such judicial or arbitral determination finds the provisions to be
unreasonable or otherwise unenforceable. In that regard, the Parties hereby agree that any judicial or arbitral authority construing this Agreement shall be empowered to sever any prohibited business activity, time period or geographical area from
the coverage of this Section 12.1 and to apply the provisions of this Section 12.1 to the remaining business activities, time periods or geographical areas not severed by such judicial or arbitral authority. The time period
during which the prohibitions set forth in this Section 12.1 shall apply shall be tolled and suspended for a period equal to the aggregate quantity of time during which any Founder violates such prohibitions in any respect. 

12.2    Non-Solicitation. Until the second (2nd) anniversary of the Execution Date, no entity or business
directly or indirectly controlled by any Founder shall, directly or indirectly, (i) solicit for employment or any similar arrangement any Founder or (ii) hire any Founder; provided, however, that this Section 12.2 shall not
apply to Founders whose employment has been terminated by the Company and its Affiliates and clause (i) hereof shall not prohibit general solicitations for employment through advertisements or other means not targeted specifically to Founders.

 ARTICLE XIII. 

MISCELLANEOUS AND GENERAL 

13.1    Amendment; Waiver. Any provision of this Agreement may be amended or waived if, and only if, such amendment
or waiver is in writing and signed, in the case of an amendment, by each Party, or in the case of a waiver, by the Party against whom the waiver is to be effective. No failure or delay by any Party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by Law except as otherwise specifically provided in this Section 13.1. 

  
 -28- 

 13.2    Counterparts. This Agreement may be executed in any
number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement. 

13.3    Governing Law and Venue; Specific Performance. 

(a)    THIS AGREEMENT SHALL BE GOVERNED BY AND INTERPRETED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK (INCLUDING SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW), WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW RULES THEREOF THAT WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAW OF ANY OTHER JURISDICTION. 

(b)    Subject to Section 13.3(c), any disputes, actions and proceedings against any Party or arising out of
or in any way relating to this Agreement shall be submitted to the HKIAC and resolved in accordance with the Arbitration Rules in force at the relevant time, except as such rules are modified or displaced by any of the provisions of this Agreement.
The official language of the arbitration shall be English and the arbitration tribunal shall consist of three arbitrators (each, an “Arbitrator”). The claimant(s), irrespective of number, shall nominate jointly one Arbitrator; the
respondent(s), irrespective of number, shall nominate jointly one Arbitrator; and a third Arbitrator will be nominated jointly by the first two Arbitrators and shall serve as chairman of the arbitration tribunal. In the event the claimant(s) or
respondent(s) or the first two Arbitrators shall fail to nominate or agree to the joint nomination of an Arbitrator or the third Arbitrator, as applicable, within the time limits specified by the Arbitration Rules, such Arbitrator shall be appointed
promptly by the HKIAC. The arbitration tribunal shall have no authority to award punitive or other punitive-type damages. The award of the arbitration tribunal shall be final and binding upon the disputing parties. Any party to an award may apply to
any court of competent jurisdiction for enforcement of such award and, for purposes of the enforcement of such award, the Parties irrevocably and unconditionally submit to the jurisdiction of any court of competent jurisdiction and waive any
defenses to such enforcement based on lack of personal jurisdiction or inconvenient forum. 

(c)    Notwithstanding the foregoing, the Parties hereby consent to and agree that in addition to any
recourse to arbitration as set out in this Section 13.3, any Party may, to the extent permitted under the Laws of the jurisdiction where application is made, seek an interim injunction from a court or other authority with competent
jurisdiction and, notwithstanding that this Agreement is governed by the Laws of the State of New York, a court or authority hearing an application for injunctive relief may apply the procedural law of the jurisdiction where the court or other
authority is located in determining whether to grant the interim injunction. For the avoidance of doubt, this Section 13.3(c) is only applicable to the seeking of interim injunctions and does not restrict the application of
Section 13.3(b) in any way. 
 (d)    The Parties agree that irreparable damage would occur in the event
that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of
this Agreement and to enforce specifically the terms and provisions of this Agreement in any court having jurisdiction, this being in addition to any other remedy to which such Party is entitled at law or in equity. 

  
 -29- 

 13.4    Notices. Any notice, request, instruction or other
document to be given hereunder by any Party to any other Party shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by facsimile, e-mail or overnight courier: 

If to the Investors, to the address listed in Exhibit A for each Investor. 

If to the Company: 
 ECMOHO
Limited 
 2F/3F, Xuhuiyuan Building No. 1000, 

Tianyaoqiao Road, Xuhui District, 

Shanghai, People’s Republic of China. 

Attention: Richard Wei 
 e-mail:
richard@ecmoho.com 
 (with a copy to 

Sullivan & Cromwell, 

Level 32, 
 101 Collins Street,

 Melbourne, Victoria 3000 

Australia. 
 Attention: Robert Chu

 fax: (+61-3) 9654-2422) 

email: chur@sullcrom.com) 
 or to such other
Person or addresses as may be designated in writing by the Party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving Party upon actual receipt,
if delivered personally, three (3) Business Days after deposit in the mail if sent by registered or certified mail, or upon confirmation of successful transmission if sent by facsimile or e-mail; provided that if given by facsimile or
e-mail, such notice, request, instruction or other document shall be confirmed by the receiving party within one (1) Business Day of receipt by dispatch pursuant to one of the other methods described herein or on the next Business Day after
deposit with an overnight courier. 
 13.5    Entire Agreement. This Agreement (including any annex hereto)
constitutes the entire agreement and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the Parties, with respect to the subject matter hereof. EACH PARTY AGREES THAT, EXCEPT FOR THE
REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT, NEITHER THE INVESTORS NOR THE COMPANY MAKES OR RELIES ON ANY OTHER REPRESENTATIONS, WARRANTIES OR INDUCEMENTS, AND EACH HEREBY DISCLAIMS ANY OTHER REPRESENTATIONS, WARRANTIES OR
INDUCEMENTS, EXPRESS OR IMPLIED, AS TO THE ACCURACY OR COMPLETENESS OF ANY OTHER INFORMATION, MADE BY, OR MADE AVAILABLE BY, ITSELF OR ANY OF ITS REPRESENTATIVES, WITH RESPECT TO, OR IN CONNECTION WITH, THE NEGOTIATION, EXECUTION OR DELIVERY OF THIS
AGREEMENT, NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE OTHER PARTY OR THE OTHER PARTY’S REPRESENTATIVES OF ANY DOCUMENTATION OR OTHER INFORMATION WITH RESPECT TO ANY ONE OR MORE OF THE FOREGOING; PROVIDED, HOWEVER, THAT NONE
OF THE FOREGOING SHALL OPERATE TO LIMIT THE LIABILITY OF ANY OTHER PERSON IN RESPECT OF ANY CLAIM OR CAUSE OF ACTION BASED ON OR ARISING OUT OF FRAUD. NO PARTY SHALL BE BOUND BY, OR BE LIABLE FOR, ANY ALLEGED REPRESENTATION, PROMISE, INDUCEMENT OR
STATEMENT OF INTENTION NOT CONTAINED HEREIN. 

  
 -30- 

 13.6    No Third-Party Beneficiaries. Each Party hereby agrees
that its respective representations, warranties and covenants set forth herein are solely for the benefit of the other Party, in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer
upon any Persons other than the Parties any rights or remedies hereunder, including the right to rely upon the representations, warranties and indemnities set forth herein. 

13.7    Severability. The provisions of this Agreement shall be deemed severable and the invalidity or
unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or
unenforceable, (i) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (ii) the remainder of
this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such
provision, or the application of such provision, in any other jurisdiction. 
 13.8    Assignment. This Agreement
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Parties. No Party may assign any of its rights or delegate any of its obligations under this Agreement, by operation of Law or otherwise, without the prior
written consent of the other Party, except that the Investor may assign any of its rights and obligations under this Agreement to any of its Affiliates (other than the Company or any of its Subsidiaries) to whom it has transferred Registrable
Investor Shares without the prior written consent of the Company (each, an “Affiliate Transferee”); provided that such Affiliate shall as a condition of effectiveness of such assignment duly execute a joinder agreement
substantially in the form of Exhibit B, whereupon such Affiliate shall have the benefits of, and shall be subject to the obligations under, this Agreement as if such Affiliate was originally included in the definition of Investor herein
and had originally been a Party hereto. 
 13.9    Fulfillment of Obligations. Any obligation of any Party to any
other Party under this Agreement, which obligation is performed, satisfied or fulfilled completely by an Affiliate of such Party, shall be deemed to have been performed, satisfied or fulfilled by such Party. 

  
 -31- 

 13.10    Termination. Except as otherwise provided in this
Agreement, this Agreement will terminate in respect of all the Parties at the earliest to occur of: (a) each Party agrees in writing to terminate this Agreement; and (b) upon the closing of a Deemed Liquidation Event and completion of the
payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and Articles. Notwithstanding the foregoing, the termination of this Agreement shall not
affect (x) the rights perfected or the obligations incurred by the Parties prior to such termination (including liability for breach of this Agreement) and (y) the rights and obligations of the Parties under Article VII and
Section 6.1. 
 [Signature Page Follows] 

  
 -32- 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	Delta Capital Growth Fund II, L.P.
		
	By:	 	  

	Name: Weigang Greg Ye
	Title: Director

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

	
	 李水蓮

	
	
By:                  
                                         
                     

	

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	ECMOHO Limited
		
	By:	 	  

		 	Name:
		 	Title:

 EXHIBIT A 

SCHEDULE OF INVESTORS 
  

					
	 Investor
	  	 Address of Investor
	  	 Type of Share

	 Delta Capital Growth Fund II, L.P.
	  	392 Jian Guo West Road, Shanghai, China	  	Series A Preferred Shares
			
	
李水蓮
	  	台灣省桃園市蘆竹區南祥路 133 號 19 樓,郵遞區號 33854	  	Series A Preferred Shares
			
	 Round A Investors
	  	[●]	  	Class A-1 Ordinary Shares
			
	 Round B Investors
	  	[●]	  	Class A-2 Ordinary Shares
			
	 Best Winner
	  	[●]	  	Class A Ordinary Shares
			
	 Liberal Rich
	  	[●]	  	Class A Ordinary Shares
			
	 Lake Zurich Partners
	  	[●]	  	Class A Ordinary Shares

  
 A-1 

 EXHIBIT B 

FORM OF JOINDER AGREEMENT 

THIS JOINDER (this “Joinder”) to the Investors Rights Agreement (the “Agreement”), dated as of [●],
2018, made by and between ECMOHO Limited, an exempted company incorporated under the Laws of Cayman Islands (the “Company”), each of the investors listed on Exhibit A attached to that Agreement (each, an
“Investor” and together the “Investors”) and certain other parties, is made and entered into as of [●], by and among [●] (the “Holder”), the Company and the Investors. Capitalized terms
used but not otherwise defined herein shall have the meanings set forth in the Agreement. 
 WHEREAS, the Holder desires to acquire certain
Shares from [specified investor].  
 NOW, THEREFORE, in
consideration of the representations, warranties and covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Joinder hereby agree as follows: 

1.    Agreement to be Bound. The Holder hereby agrees that upon execution of this Joinder, the Holder shall become
a party to the Agreement and shall be fully bound by, and subject to, all of the covenants, terms and conditions of the Agreement as though the Holder was [specified
investor] on the date thereof and shall be deemed to be [specified investor] for all purposes thereof. 

2.    Representations and Warranties of the Holder. By executing and delivering this Joinder, the Holder represents
and warrants that the Holder is an Affiliate of [specified investor]. 

3.    Counterparts. This Joinder may be executed in separate counterparts, including by facsimile, each of which
shall be an original and all of which taken together shall constitute one and the same agreement. 

4.    Notices. For purposes of Section 13.4 of the Agreement, all notices, demands or other
communications to the Holder shall be directed to: 
 [Name] 

[Address] 

[Attention] 

[Facsimile Number] 

5.    Governing Law. THIS JOINDER SHALL BE GOVERNED BY AND INTERPRETED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK (INCLUDING SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW), WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW RULES THEREOF THAT WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAW OF ANY OTHER JURISDICTION. 

  
 B-1 

 6.    Descriptive Headings. The descriptive headings of this
Joinder are inserted for convenience only and do not constitute a part of this Joinder. 
 ***** 

IN WITNESS WHEREOF, the parties hereto have executed this Joinder as of the date first written above. 

 

			
	[Holder]	 	
	
	By:                                   
                           
	Name:	 	
	Title:	 	

  

			
	Acknowledged and agreed by:
	
	ECMOHO Limited
	
	By:                                   
                           
	Name:
	Title:
	
	[Investors]
	
	By:                                   
                           
	Name:
	Title:

  
 B-2EX-10.18

 Exhibit 10.18 

 
  

 
 INVESTORS RIGHTS AGREEMENT 

by and among 
 ECMOHO
LIMITED, 
 BEHEALTH LIMITED, 

UHEALTH LIMITED, 

ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, 

SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., 

WANG YING, 
 ZENG
QINGCHUN 
 and 

EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO 

Dated as of August 7, 2018 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I.	  

	
	INTRODUCTORY MATTERS	  

			
	 1.1
	 	 Defined Terms
	  	 	2	 
	 1.2
	 	 Interpretation; Construction
	  	 	8	 
	
	ARTICLE II.	  

	
	DEMAND REGISTRATION	  

			
	 2.1
	 	 Right to Request Demand Registration
	  	 	8	 
	 2.2
	 	 Effective Demand Registration
	  	 	8	 
	 2.3
	 	 Number of Demand Registrations
	  	 	9	 
	 2.4
	 	 Selection of Underwriters
	  	 	9	 
	 2.5
	 	 Priority on Demand Registrations
	  	 	9	 
	 2.6
	 	 Effective Period of Demand Registrations
	  	 	9	 
	
	ARTICLE III.	  

	
	PIGGYBACK REGISTRATION	  

			
	 3.1
	 	 Right to Request a Piggyback Registration
	  	 	9	 
	 3.2
	 	 Selection of Underwriters
	  	 	10	 
	 3.3
	 	 Priority on Primary Piggyback Registrations
	  	 	10	 
	 3.4
	 	 Priority on Secondary Piggyback Registrations
	  	 	10	 
	 3.5
	 	 Basis of Participation
	  	 	11	 
	
	ARTICLE IV.	  

	
	F-3 REGISTRATION	  

			
	 4.1
	 	 Right to Request F-3 Registration
	  	 	11	 
	 4.2
	 	 Effective F-3 Registration
	  	 	11	 
	 4.3
	 	 Number of F-3 Registrations
	  	 	11	 
	 4.4
	 	 Selection of Underwriters
	  	 	11	 
	 4.5
	 	 Priority on F-3 Registrations
	  	 	12	 
	 4.6
	 	 Effective Period of F-3 Registrations
	  	 	12	 

  
 i 

							
	ARTICLE V.	  

	
	SUSPENSION PERIOD	  

			
	 5.1
	 	 Suspension Period
	  	 	12	 
	 5.2
	 	 Additional Registration Rights
	  	 	13	 
	
	ARTICLE VI.	  

	
	REGISTRATION EXPENSES	  

			
	 6.1
	 	 Registration Expenses
	  	 	13	 
	 6.2
	 	 Termination of Registration Rights
	  	 	13	 
	
	ARTICLE VII.	  

	
	MANAGEMENT AND INFORMATION RIGHTS	  

			
	 7.1
	 	 Delivery of Financial Statements
	  	 	13	 
	 7.2
	 	 Inspection Rights
	  	 	14	 
	 7.3
	 	 Termination of Information Rights
	  	 	14	 
	 7.4
	 	 Confidentiality
	  	 	15	 
	
	ARTICLE VIII.	  

	
	RIGHTS AND RESTRICTIONS REGARDING SHARE TRANSFERS	  

			
	 8.1
	 	 Right of First Offer
	  	 	15	 
	 8.2
	 	 Right of First Refusal
	  	 	16	 
	 8.3
	 	 Co-Sale Right
	  	 	18	 
	 8.4
	 	 Prohibited Transfers
	  	 	19	 
	 8.5
	 	 Restrictions on Issuance by Group Company
	  	 	20	 
	 8.6
	 	 Founder Transfers
	  	 	20	 
	 8.7
	 	 Termination of Rights and Restrictions
	  	 	20	 
	
	ARTICLE IX.	  

	
	DRAG-ALONG OBLIGATION	  

			
	 9.1
	 	 Drag-Along Rights
	  	 	20	 
	 9.2
	 	 Termination of Drag-Along Rights
	  	 	22	 
	
	ARTICLE X.	  

	
	GOVERNANCE AND ADDITIONAL COVENANTS	  

			
	 10.1
	 	 Board of Directors
	  	 	22	 
	 10.2
	 	 Matters Requiring Requisite Approval
	  	 	23	 

  
 ii 

							
	 10.3
	 	 Matters Requiring Approval of the Board of Directors
	  	 	24	 
	 10.4
	 	 Insurance
	  	 	25	 
	 10.5
	 	 Termination of Covenants
	  	 	25	 
	
	ARTICLE XI.	  

	
	CONFIDENTIALITY	  

			
	 11.1
	 	 Confidentiality
	  	 	25	 
	 11.2
	 	 Damages Not an Adequate Remedy
	  	 	27	 
	 11.3
	 	 Survival
	  	 	27	 
	
	ARTICLE XII.	  

	
	NON-COMPETITION; NON-SOLICITATION	  

			
	 12.1
	 	 Non-Competition
	  	 	27	 
	 12.2
	 	 Non-Solicitation
	  	 	28	 
	
	ARTICLE XIII.	  

	
	MISCELLANEOUS AND GENERAL	  

			
	 13.1
	 	 Amendment; Waiver
	  	 	28	 
	 13.2
	 	 Counterparts
	  	 	29	 
	 13.3
	 	 Governing Law and Venue; Specific Performance
	  	 	29	 
	 13.4
	 	 Notices
	  	 	30	 
	 13.5
	 	 Entire Agreement
	  	 	31	 
	 13.6
	 	 No Third-Party Beneficiaries
	  	 	31	 
	 13.7
	 	 Severability
	  	 	31	 
	 13.8
	 	 Assignment
	  	 	31	 
	 13.9
	 	 Fulfillment of Obligations
	  	 	32	 
	 13.10
	 	 Termination
	  	 	32	 

  

							
	 Exhibit A:
	 	 Schedule of Investors
	  			
			
	 Exhibit B:
	 	 Form of Joinder Agreement
	  			

  
 iii 

 INVESTORS RIGHTS AGREEMENT 

THIS INVESTORS RIGHTS AGREEMENT (including the exhibits hereto, this “Agreement”), dated as of August 7, 2018 (the
“Execution Date”), is made by and among: 
  

	1.	 ECMOHO Limited (the “Company”), an exempted company incorporated under the laws of the Cayman
Islands; 

  

	2.	 ECMOHO (Hong Kong) Health Technology Limited (“ECMOHO Hong Kong”), a limited company
incorporated under the laws of Hong Kong; 

  

	3.	 Shanghai ECMOHO Health Biotechnology Co., Ltd.
(上海易恒健康生物科技有限公司) (“ECMOHO Shanghai”), a limited liability company established
under the laws of the People’s Republic of China; 

  

	4.	 Founders (as defined below) and Founder Holding Companies (as defined below); and 

 

	5.	 each of the investors listed on Exhibit A, as amended from time to time, attached to this Agreement
(each, an “Investor” and together, the “Investors”). 

 The Company, ECMOHO Hong Kong,
ECMOHO Shanghai and their respective Subsidiaries (as defined below) are referred to collectively herein as the “Group Companies”, and each a “Group Company”. “Group” refers to all the Group
Companies collectively. All of the signatories to this Agreement are collectively referred to as the “Parties” and each individually as a “Party”. 

RECITALS 

WHEREAS, CID Greater China Fund V, L.P. (“CID”), STCH Investment Inc. (“STCH”, and
together with CID, the “Round A Investors”), certain other investors and Shanghai ECMOHO Health Biotechnology Co, Ltd. (“ECMOHO Shanghai”) are parties to a shareholders agreement, dated as of August 18, 2015
(the “Round A Shareholders Agreement”); 
 WHEREAS, Smart Warrior Limited, CID, STCH, Shanghai Yihao Enterprise
Management Partnership (Limited Partnership) (上海奕好企业管理合伙企业(有限合伙)), together, the “Round B
Investors”), certain other investors and ECMOHO Shanghai are parties to a shareholders agreement, dated as of April 19, 2016 (the “Round B Shareholders Agreement”); 

WHEREAS, on August 7, 2018, the Company issued certain number of shares of Class A Ordinary Shares to Best Winner
Limited, Lake Zurich Partners Limited and Liberal Rich Limited; 
 WHEREAS, on August 7, 2018, the Company issued certain
number of shares of Class B Ordinary Shares to the Founder Holding Companies (as defined below); 

 WHEREAS, the Round A Investors, the Round B Investors and the Company (or
their respective affiliates) are parties to a share subscription agreement, dated as of August 7, 2018 (the “Round A and B Share Subscription Agreement”), pursuant to which the Company agreed to sell, and each of the Round A
Investors and Round B Investors agreed to subscribe for, that number of Class A-1 and Class A-2 Ordinary Shares of the Company, set forth opposite such Round A
Investor’s or Round B Investor’s name on exhibit A thereto; 
 WHEREAS, the Company and certain of the Investors (the
“Round C Investors”) are parties to a Series A preferred share purchase agreement, dated as of August 2, 2018 (the “Series A Share Purchase Agreement”), pursuant to which the Company agreed to sell, and
the Round C Investors agreed to purchase, that number of shares of Series A Preferred Shares of the Company (the “Series A Preferred Shares”), set forth opposite such Round C Investor’s name on exhibit A thereto; 

WHEREAS, Behealth Limited, Delta Capital Growth Fund II, L.P. and
李水莲 have entered into an ordinary share purchase agreement, dated as of August 2, 2018 (the “Ordinary Share Purchase Agreement”), pursuant to
which Behealth Limited agreed to sell, and each of Delta Capital Growth Fund II, L.P. and 李水莲 agreed to
purchase, a certain number of shares of Class A Ordinary Shares of the Company; and 
 WHEREAS, the Parties desire to
address certain relationships among themselves with respect to registration rights and certain other matters. 
 NOW,
THEREFORE, in consideration of the premises, and of the representations, warranties, covenants and agreements contained herein, the Parties agree as follows: 

ARTICLE I. 

INTRODUCTORY MATTERS 

1.1    Defined Terms. As used in this Agreement: 

(a)    “ADSs” are American depositary shares of the Company; 

(b)    “Affiliate” means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under common control with, such specified Person; 

(c)    “Affiliate Investor”, and collectively, “Affiliate Investors”, mean CID, STCH
and Delta, (i) in the case of CID or STCH, so long as it owns at least 50% of the Shares that CID or STCH, as applicable, owns immediately following the closing of the Round A and B Share Subscription Agreement, and (ii) in the case of
Delta, so long as it owns at least 50% of the Shares that Delta owns immediately following the closing of the Series A Share Purchase Agreement. 

(d)    “Affiliate Transferee” has the meaning set forth in Section 13.8; 

(e)    “Agreement” has the meaning set forth in the Preamble; 

  
 -2- 

 (f)    “Arbitration Rules” means the arbitration rules
of the Hong Kong International Arbitration Centre; 
 (g)    “Arbitrator” has the meaning set forth in
Section 13.3(b); 
 (h)    “Big 4 Accounting Firm” refers to any of Deloitte
Touche Tohmatsu Limited, Ernst & Young, KPMG and PricewaterhouseCoopers; 
 (i)    “Board of
Directors” means the board of directors of the Company; 
 (j)    “Budget” has the meaning
set forth in Section 7.1(c); 
 (k)    “Business Day”, and collectively,
“Business Days”, mean a day (other than a Saturday or Sunday or public holiday) on which banks are open for general corporate business in each of Shanghai, People’s Republic of China; George Town, Cayman Islands; Hong Kong; and
New York, United States of America; 
 (l)    “CID” means CID Greater China Fund V, L.P.; 

(m)    “Class A Ordinary Share” means a class A ordinary share in the capital of the
Company, par value of US$0.00001 per share; 
 (n)    “Class B Ordinary Share”
means a class B ordinary share in the capital of the Company, par value of US$0.00001 per share; 

(o)    “Company” has the meaning set forth in the Preamble; 

(p)    “Competitor” means a Person engaged, directly or indirectly (including through any partnership,
limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in the health and wellness related e-commerce industry in the Chinese market, but shall not include any financial investment
firm or collective investment vehicle that, together with its Affiliates, holds less than twenty percent (20%) of the outstanding equity of any Competitor; 

(q)    “Constitutive Documents” means, with respect to a Person, such Person’s certificate of
incorporation, formation or registration (including, if relevant, certificates of change of name), memorandum of association, articles of association or incorporation, charter, bylaws, trust deed, trust instrument, or equivalent documents, in each
case as amended; and means, with respect to limited liability companies of the People’s Republic of China, articles of association or equivalent documents; 

(r)    “Control”, including the correlative terms “controlling”, “controlled
by” and “under common control with”, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of an entity, whether through ownership of voting securities, by
contract or otherwise; 
 (s)    “Deemed Liquidation Event” has the meaning set forth in the
Memorandum and Articles; 

  
 -3- 

 (t)    “Delta” means Delta Capital Growth Fund II,
L.P.; 
 (u)    “Demand Registration” has the meaning set forth in
Section 2.1; 
 (v)    “Derivative Securities” means any securities or
rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Ordinary Shares, including options and warrants. 

(w)    “Designated Holders” means each of the Investors and each of their respective Affiliate
Transferees; 
 (x)    “ECMOHO Hong Kong” means ECMOHO (Hong Kong) Health Technology Limited, a
limited company established under the Laws of Hong Kong; 
 (y)    “ECMOHO Shanghai” means Shanghai
ECMOHO Health Biotechnology Co, Ltd. (上海易恒健康生物科技有限公司), a limited liability company established under the Laws of the PRC; 

(z)    “Employee Share Option Plan” means the 2018 Employee Share Option Plan duly adopted by the Board
of Directors and approved by the Company; 
 (aa)    “Exchange Act” means the U.S. Securities Exchange
Act of 1934, as amended; 
 (bb)    “Execution Date” has the meaning set forth in the Preamble; 

(cc)    “F-3 Registration” has the meaning set forth in
Section 4.1; 
 (dd)    “Founders” means Ying WANG (王影) (PRC identification number: *** and Qingchun
Zeng(曾庆春) (PRC identification number: ***); 

(ee)    “Founder Holding Companies” means Behealth Limited and Uhealth Limited; 

(ff)    “Fully Exercising Investor” has the meaning set forth in
Section 8.1(b); 
 (gg)    “Governmental Entity” means any U.S. or non-U.S. governmental or regulatory authority, agency, commission, body, court or other legislative, executive or judicial governmental entity; 

(hh)    “HKIAC” means the Hong Kong International Arbitration Centre; 

(ii)    “IFRS” means the International Financial Reporting Standards issued by the International
Accounting Standards Board; 
 (jj)    “Investor” has the meaning set forth in the Preamble; 

  
 -4- 

 (kk)    “Investor Beneficial Owners” has the meaning
set forth in Section 8.1; 
 (ll)    “Investor Director”, and collectively,
“Investor Directors”, means any of the Preferred Share Director, the Round A Director and the Round B Director. 

(mm)    “Investor Share”, and collectively, “Investor Shares”, means any Share held by
an Investor. 
 (nn)    “Law”, and collectively, “Laws”, mean any federal, state,
local or foreign law, statute or ordinance, common law, or any rule, regulation, standard, judgment, order, writ, injunction, decree, arbitration award, agency requirement, license or permit of any Governmental Entity; 

(oo)    “Maximum Offering Size” has the meaning set forth in Section 2.5; 

(pp)    “Memorandum and Articles” means the memorandum of association and articles of association of the
Company adopted by a special resolution of the shareholders of the Company on August 2, 2018; 

(qq)    “New Securities” means equity securities issued by the Company after the date hereof;
provided that securities created pursuant to a stock split, dividend or other subdivision of Ordinary Shares are not New Securities; 

(rr)    “Offer Notice” has the meaning set forth in Section 8.1(a); 

(ss)    “Offered Shares” has the meaning set forth in Section 8.2(a); 

(tt)    “Ordinary Shares” means the ordinary shares of the Company, including the Class A Ordinary
Shares and the Class B Ordinary Shares; 
 (uu)    “Ordinary Share Purchase Agreement” has the
meaning set forth in the Recitals; 
 (vv)    “Original Shares” means ordinary shares with a par value
of US$0.0001 each in the capital of the Company; 
 (ww)    “Party” has the meaning set forth in the
Preamble; 
 (xx)    “Person” means any individual, corporation, partnership, trust, limited liability
company, association or other entity; 
 (yy)    “Piggyback Registration” has the meaning set forth in
Section 3.1; 
 (zz)    “Preferred Share Director” means Greg Ye, as the
member of the Board of Directors appointed by the Round C Investors; 
 (aaa)    “Proposed ROFR
Seller” has the meaning set forth in Section 8.2(a); 
 (bbb)    “Proposed
ROFR Purchaser” has the meaning set forth in Section 8.2(a); 

  
 -5- 

 (ccc)    “Qualified IPO” means a firm-commitment
underwritten initial public offering by the Company of its Ordinary Shares (or the ADSs thereof) on the New York Stock Exchange or NASDAQ Stock Market in the United States, the Hong Kong Stock Exchange or any other exchange in any other jurisdiction
(or any combination of such exchanges and jurisdictions) acceptable to the Company, in any case with a pre-initial public offering valuation of at least US$600,000,000 and with aggregate offering proceeds
(before deduction of underwriting fees, commissions or expenses) to the Company of not less than US$120,000,000 (or any cash proceeds of other currency of equivalent value); 

(ddd)    “Registrable Investor Shares” means, the Investor Shares and any other securities issued or
issuable with respect to such Investor Shares by way of a share split, share dividend, recapitalization, exchange or similar event or otherwise; provided, however, that as to any Investor Share, such Share shall cease to be a
Registrable Investor Share when: (i) a Registration Statement (as defined herein) covering such Registrable Investor Share has been declared effective and such Registrable Investor Share has been disposed of pursuant to such effective
Registration Statement; (ii) such Registrable Investor Share shall have been sold pursuant to Rule 144 (or any similar provision then in effect) under the Securities Act; (iii) such Registrable Investor Share is otherwise transferred in a
private transaction and is no longer held by any Investor; or (iv) such Registrable Investor Share ceases to be outstanding; 

(eee)    “Registrable Shares” means, at any time: (i) any of the Registrable Investor Shares; and
(ii) any Ordinary Shares not previously issued to the public and currently held or hereafter acquired by a Designated Holder, and any other securities issued or issuable with respect to such Ordinary Shares by way of a share split, share
dividend, recapitalization, exchange or similar event or otherwise; provided, however, that as to any Investor Share, such Investor Share shall cease to be a Registrable Investor Share when: (i) a Registration Statement (as
defined herein) covering such Registrable Investor Share has been declared effective and such Registrable Investor Share has been disposed of pursuant to such effective Registration Statement; (ii) such Registrable Investor Share shall have
been sold pursuant to Rule 144 (or any similar provision then in effect) under the Securities Act; (iii) such Registrable Investor Share is otherwise transferred in a private transaction and is no longer held by any Investor; or (iv) such
Registrable Investor Share ceases to be outstanding; 
 (fff)    “Registration Statement” means any
registration statement filed pursuant to the Securities Act; 
 (ggg)    “Requisite Approval” means
the consent of at least fifty-five percent (55%) of the voting power of the Investors; 
 (hhh)    “ROFR
Closing” has the meaning set forth in Section 8.2(c); 
 (iii)    “ROFR
Holder” means each of the Investors and any of its Affiliates and its permitted assignees to whom its rights under Section 8.2 have been duly assigned in accordance with this Agreement; 

(jjj)    “ROFR Notice” has the meaning set forth in Section 8.2(a); 

(kkk)    “ROFR Offer” has the meaning set forth in Section 8.2(b); 

  
 -6- 

 (lll)    “Round A Director” means any member of the
Board of Directors appointed by the Round A Investors; 
 (mmm)    “Round A Investor”, and
collectively, “Round A Investors”, have the meaning set forth in the Recitals; 

(nnn)    “Round A Shareholders Agreement” has the meaning set forth in the Recitals; 

(ooo)    “Round A and B Share Subscription Agreement” has the meaning set forth in the Recitals; 

(ppp)    “Round B Director” means any member of the Board of Directors appointed by the Round B
Investors; 
 (qqq)    “Round B Investor”, and collectively, “Round B Investors”,
have the meaning set forth in the Recitals; 
 (rrr)    “Round B Shareholders Agreement” has the
meaning set forth in the Recitals; 
 (sss)    “Round C Investor”, and collectively, “Round C
Investors”, have the meaning set forth in the Preamble; 
 (ttt)    “SEC” means the U.S.
Securities and Exchange Commission; 
 (uuu)    “Securities Act” means the U.S. Securities Act of
1933, as amended; 
 (vvv)    “Series A Preferred Shares” has the meaning set forth in the Recitals;

 (www)    “Shares” means any of the issued and outstanding shares of all classes of share capital of
the Company; 
 (xxx)    “STCH” means STCH Investment Inc.; 

(yyy)    “Subsidiary”, and collectively, “Subsidiaries”, mean, with respect to any
Person, any and all corporations, partnerships, limited liability companies, joint ventures, associations, variable interest entities or other entities controlled by such Person directly or indirectly through one or more intermediaries; 

(zzz)    “Suspension Period” has the meaning set forth in Section 5.1(a); 

(aaaa)    “Tax” means all forms of taxation whether direct or indirect and whether levied by reference
to income, profits, gains, net wealth, asset values, turnover, added value or other reference and statutory, governmental, state, provincial, local governmental or municipal impositions, duties, contributions, rates and levies (including without
limitation social security contributions and any other payroll taxes), whenever and wherever imposed (whether imposed by way of a withholding or deduction for or on account of tax or otherwise) and in respect of any person and all penalties,
charges, costs and interest relating thereto; 

  
 -7- 

 (bbbb)    “Taxing Authority” means any taxing or other
authority competent to impose any liability in respect of Tax or responsible for the administration and/or collection of Tax or enforcement of any law in relation to Tax; 

(cccc)    “U.S. Dollars” or “US$” means United States dollars, the lawful currency of
the United States of America; and 
 (dddd)    “U.S. GAAP” means generally accepted accounting
principles in the United States as in effect from time to time. 
 1.2    Interpretation; Construction. 

(a)    The table of contents and headings herein are for convenience of reference only, do not constitute part of this
Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to an annex, exhibit or section, such reference shall be to an annex, exhibit or section to this Agreement
unless otherwise indicated. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. 

(b)    The Parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity
or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any
provision of this Agreement. 
 ARTICLE II. 

DEMAND REGISTRATION 

2.1    Right to Request Demand Registration. Subject to the provisions hereof, so long as an Affiliate Investor
continues to be an Affiliate of the Company, such Affiliate Investor may, upon the request of holders of at least twenty-five percent (25%) of the Registrable Shares, at any time commencing the earlier of: (i) one hundred eighty (180) days
after a Qualified IPO or (ii) the fifth (5th) anniversary of the Execution Date, request registration under the Securities Act, of all or part of the Registrable Investor Shares separate from an F-3
Registration (a “Demand Registration”); provided, however, that the Company shall not be obligated to effect a Demand Registration if the Affiliate Investor and any Designated Holders that have requested the
opportunity to include Registrable Shares in the Demand Registration pursuant to this Agreement propose to sell Registrable Shares at an aggregate price (based on the then-current market prices) to the public of less than US$50,000,000. 

2.2    Effective Demand Registration. Subject to the provisions of this Article II and
Section 5.1, the Company shall use reasonable efforts to: (i) publicly file with the SEC, no more than one hundred twenty (120) days after receipt of an Affiliate Investor’s request pursuant to
Section 2.1, a Registration Statement registering, subject to Section 2.6, such number of Registrable Investor Shares as requested by any Affiliate Investor to be so registered pursuant to
Section 2.1; and (ii) cause such Registration Statement to be declared effective by the SEC as soon as practicable thereafter. 

  
 -8- 

 2.3    Number of Demand Registrations. Each Affiliate Investor
may request up to two (2) Demand Registrations. The Company shall not count a request for registration as a Demand Registration for purposes of this Section 2.3 unless and until the Registration Statement filed with
the SEC pursuant to such request has become effective or as otherwise specified in Section 2.6 or Section 5.1. 

2.4    Selection of Underwriters. The Company shall have the right to select the managing underwriter or
underwriters to administer any such offering. 
 2.5    Priority on Demand Registrations. If the managing
underwriters of the Demand Registration advise the Company and the Affiliate Investor that in their opinion the number of Shares proposed to be included in the Demand Registration exceeds the number of Shares that can be sold in such underwritten
offering without materially delaying or jeopardizing the success of the offering (including the price per Share of the Registrable Shares proposed to be sold in such underwritten offering) (the “Maximum Offering Size”), the Company
shall include in such Demand Registration the number of Registrable Shares requested to be included therein by the Affiliate Investor and the Designated Holders pro rata among all such Affiliate Investor and Designated Holders, such that the
aggregate number of Shares (including any Registrable Shares) proposed to be registered by the Company and all such holders does not exceed the Maximum Offering Size. 

2.6    Effective Period of Demand Registrations. The Company shall use reasonable efforts to keep any Demand
Registration continuously effective for a period equal to thirty (30) days from the date on which the Registration Statement is declared effective by the SEC or such shorter period that shall terminate when all of the Registrable Investor
Shares covered by such Demand Registration have been sold. If the Company shall withdraw any Demand Registration pursuant to Section 5.1 before the earlier of: (i) the date when such thirty (30) days end; and
(ii) the date when all of the Registrable Investor Shares covered by such Demand Registration have been sold pursuant thereto, the Affiliate Investor shall be entitled to a replacement Demand Registration, which shall be subject to all of the
provisions of this Agreement. 
 ARTICLE III. 

PIGGYBACK REGISTRATION 

3.1    Right to Request a Piggyback Registration. If the Company proposes to register any Shares under the
Securities Act (a “Piggyback Registration”) (other than on a Registration Statement on Form F-4, Form S-4, Form
F-8 or Form S-8) at any time until the first date on which there are no Registrable Investor Shares outstanding, whether for its own account or for the account of one or
more holders of Shares (excluding any Demand Registration pursuant to Article II, which shall be governed exclusively by Article II, and any F-3 Registration pursuant to Article IV, which
shall be governed exclusively by Article IV), and the form of Registration Statement is suitable for the registration of Registrable Investor Shares, the Company shall give written notice to the Affiliate Investors at least ten (10) days
before the anticipated filing date of its intention to effect such a registration and, subject to Section 3.3, Section 3.4 and Section 3.5, shall include in such
Registration Statement and in any offering of Shares to be made pursuant to that Registration Statement such number of Registrable Investor Shares that the Affiliate Investor may request in writing to the Company to be included in the Registration
Statement; provided that such written request by an Affiliate Investor must be made no later than five (5) days after receipt by the Affiliate Investor of the notice and the Company shall have no obligation to proceed with any Piggyback
Registration and may abandon, terminate and/or withdraw the Piggyback Registration for any reason at any time prior to the pricing thereof. There shall be no limit on the number of times any Investor may request registration of Registrable Investor
Shares under this Section 3.1. 

  
 -9- 

 3.2    Selection of Underwriters. The Company shall have the
right to select the managing underwriter or underwriters to administer any underwritten offering pursuant to any Piggyback Registration. 

3.3    Priority on Primary Piggyback Registrations. If a Piggyback Registration is initiated as a primary
underwritten offering on behalf of the Company, and the managing underwriters advise the Company that in their opinion the number of Shares (including any Registrable Shares) proposed to be included in such Piggyback Registration exceeds the Maximum
Offering Size, the Company shall include in such Piggyback Registration: 
 (a)    first, such number of Shares the
Company proposes to include in the Piggyback Registration; and 
 (b)    second, to the extent the number of Shares
included in the Piggyback Registration under clause (a) is: 
 (i)    less than the Maximum Offering
Size, the number of Registrable Investor Shares requested to be included therein by the Affiliate Investor in an aggregate amount not to exceed the Maximum Offering Size less the Shares included under clause (i), such that the sum of
the Shares proposed under clause (a) plus the number of Registrable Investor Shares proposed to be registered under clause (b) does not exceed the Maximum Offering Size; and 

(ii)    greater than or equal to the Maximum Offering Size, the number of Registrable Investor Shares
requested to be included therein by the Affiliate Investor in an aggregate amount not to exceed the Maximum Offering Size. 

3.4    Priority on Secondary Piggyback Registrations. Subject to Section 3.3, if a
Piggyback Registration is initiated as a secondary underwritten registration on behalf of the holders of Shares, and the managing underwriters advise the Company that in their opinion the number of Shares (including any Registrable Shares) proposed
to be included in such Piggyback Registration exceeds the Maximum Offering Size, the Company shall include in such Piggyback Registration the number of Registrable Shares requested to be included therein by the Affiliate Investor and the Designated
Holders and the number of Shares requested, and agreed by the Company, to be included therein by the holders of Shares, pro rata among all such holders, such that the aggregate number of Shares (including any Registrable Shares) proposed to be
registered by the Company and all such holders does not exceed the Maximum Offering Size. 

  
 -10- 

 3.5    Basis of Participation. No Affiliate Investor may sell
Registrable Investor Shares in any offering pursuant to a Piggyback Registration unless it: (i) agrees to sell such Registrable Investor Shares on the same basis provided in the underwriting or other distribution arrangements approved by the
Company and that apply to the Company and/or any holders of Shares (including Registrable Shares) involved in such Piggyback Registration; and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements,
lockups and other documents required under the terms of such arrangements. 
 ARTICLE IV. 

F-3 REGISTRATION 

4.1    Right to Request F-3 Registration. Subject to the provisions hereof
and the eligibility of the Company to use Form F-3, an Affiliate Investor may at any time commencing twelve (12) months after the Execution Date request that the Company file a Registration Statement on
Form F-3 (or an amendment or supplement to an existing Registration Statement on Form F-3) for a public offering of all or such portion of the Registrable Investor
Shares owned and designated by such Affiliate Investor pursuant to Rule 415 promulgated under the Securities Act or otherwise (an “F-3 Registration”); provided, however, that the
Company shall not be obligated to effect an F-3 Registration if the Affiliate Investor together with any Designated Holders that have requested the opportunity to include Registrable Shares in the F-3 Registration pursuant to this Agreement propose to sell Registrable Shares at an aggregate price (based on the then-current market prices) to the public of less than US$15,000,000. 

4.2    Effective F-3 Registration. Subject to the provisions of this
Article IV and Section 5.1, the Company shall use reasonable efforts to: (i) publicly file with the SEC, no more than ninety (90) days after receipt of an Affiliate Investor’s request pursuant to
Section 4.1, a Registration Statement on Form F-3 registering, subject to Section 4.5, such number of Registrable Investor Shares as requested by the
Affiliate Investor to be so registered pursuant to Section 4.1; and (ii) cause such Registration Statement to be declared effective by the SEC as soon as practicable thereafter. If permitted under the Securities Act,
such Registration Statement shall be one that is automatically effective upon filing. 
 4.3    Number of F-3 Registrations. Except as otherwise provided herein, there shall be no limit on the number of times that the Affiliate Investor may request an F-3 Registration, except
that no more than one (1) F-3 Registration may be requested within any 12-month period. The Company shall not deem any registration requested by the Affiliate
Investor pursuant to Section 4.1 to be a Demand Registration for purposes of Section 2.3. 

4.4    Selection of Underwriters. The Company shall have the right to select the managing underwriter or
underwriters to administer any such offering. 

  
 -11- 

 4.5    Priority on F-3
Registrations. If the managing underwriters of the requested F-3 Registration advise the Company and the Affiliate Investor that in their opinion the number of Registrable Shares proposed to be included in
the F-3 Registration exceeds the Maximum Offering Size, the Company shall include in such F-3 Registration the number of Registrable Shares requested to be included
therein by the Affiliate Investor and the Designated Holders pro rata among all such Affiliate Investor and Designated Holders, such that the aggregate number of Shares (including any Registrable Shares) proposed to be registered by the Company and
all such holders does not exceed the Maximum Offering Size. 
 4.6    Effective Period of F-3 Registrations. The Company shall use reasonable efforts to keep any F-3 Registration effective until the earlier of: (i) the date that all of the Registrable
Investor Shares covered by such F-3 Registration have been sold; and (ii) the date as of which the Affiliate Investor is permitted to sell its Registrable Investor Shares without registration pursuant to
Rule 144 under the Securities Act without volume limitations or other restrictions on transfer thereunder. 
 ARTICLE V. 

SUSPENSION PERIOD 

5.1    Suspension Period. 

(a)    The Company may (i) delay the filing or effectiveness of a Registration Statement in conjunction with a
Demand Registration or an F-3 Registration or (ii) prior to the pricing of any offering of Registrable Investor Shares pursuant to a Demand Registration or an F-3
Registration, delay such offering (and, if it so chooses, withdraw any Registration Statement that has been filed) if any Founder, in consultation with the Board of Directors, determines in good faith (x) that proceeding with such an offering
would require the Company to disclose material information that would not otherwise be required to be disclosed at that time and that the disclosure of such information at that time would not be in the best interests of the Company or its
shareholders or (y) that the registration or offering to be delayed would, if not delayed, materially and adversely affect the Company, taken as a whole, or materially interfere with, or jeopardize the success of, any pending or proposed
material transaction, including any debt or equity financing, any acquisition or disposition, any recapitalization or reorganization or any other material transaction. Any period during which the Company has delayed a filing, an effective date or an
offering pursuant to this Section 5.1(a) is herein called a “Suspension Period”. 

(b)    If pursuant to Section 5.1(a) the Company delays a Demand Registration or withdraws a
Registration Statement, as the case may be, requested by any Investor, then such Investor shall be entitled to withdraw such request and such request shall not count against the limitations on registrations set forth in
Section 2.3. The Company shall provide prompt written notice to such Investor of the commencement and termination of any Suspension Period and any withdrawal of a Registration Statement pursuant to
Section 5.1(a). Such Investor shall keep the existence of each Suspension Period confidential and refrain from making offers and sales of Registrable Investor Shares during each Suspension Period. In no event shall:
(i) the Company deliver notice of a Suspension Period to any Investor more than three times in any 12-month period; or (ii) a Suspension Period or Suspension Periods be in effect for ninety
(90) consecutive days or more in any 12-month period. 

  
 -12- 

 5.2    Additional Registration Rights. The Company agrees not to
grant registration or offering rights senior to those granted to the Affiliate Investors to any other holder of the Company’s securities without the prior approval of a majority of the Affiliate Investors. 

ARTICLE VI. 

REGISTRATION EXPENSES 

6.1    Registration Expenses. The Company shall bear all expenses incident to the Company’s performance of or
compliance with this Agreement, including without limitation (i) all registration and filing fees, (ii) fees and expenses of compliance with securities Laws, (iii) printing expenses, (iv) fees and disbursements of counsel for the
Company, (v) all independent certified public accountants and other Persons retained by the Company and (vi) all “road show” expenses incurred in respect of any underwritten offering, including all costs of travel, lodging and
meals (such expenses, the “Registration Expenses”). Each Investor participating in a registration shall bear such Investor’s proportionate share (based on the total number of shares sold in such registration other than for the
account of the Company) of all underwriting discounts and commissions associated with any sale of Registrable Investor Shares and shall pay all of its own costs and expenses, including all fees and expenses of any counsel (and any other advisers)
representing it, any share transfer taxes and duties, and ADS conversion fees, if any. 
 6.2    Termination of
Registration Rights. Notwithstanding anything to the contrary in this Agreement, the Company’s obligations under Article II through VI (inclusive) with respect to any Affiliate Investor, shall automatically terminate at the
date on which, in the opinion of counsel to the Company, all Registrable Investor Shares may be sold without registration and without regard to any volume limitation requirement pursuant to Rule 144 promulgated under the Securities Act. 

ARTICLE VII. 

MANAGEMENT AND INFORMATION RIGHTS 

7.1    Delivery of Financial Statements. The Company covenants and agrees that, commencing on the date of this
Agreement, for so long as any Investor holds any shares of the Company, the Company shall deliver to each Investor, provided that the Board of Directors has not reasonably determined that such Investor is a Competitor of the Company: 

(a)    as soon as practicable, but in any event within one hundred twenty (120) days after the end of each fiscal year of
the Company (i) a balance sheet as of the end of such year, (ii) an income statement for such year, and (iii) a statement of cash flows for such year, all such financial statements prepared in accordance with U.S. GAAP or IFRS,
audited and certified by independent public accountants of a Big 4 Accounting Firm selected by the Company; 

  
 -13- 

 (b)    as soon as practicable, but in any event within forty-five
(45) days after the end of each fiscal quarters of the Company (i) an unaudited balance sheet as of the end of such quarter, (ii) an unaudited income statement for such quarter, and (iii) an unaudited statement of cash flows for
such quarter prepared in accordance with U.S. GAAP or IFRS; and 
 (c)    as soon as practicable, but in any event
within ten (10) days after the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”), approved by the Board of Directors, including balance sheets, income statements and
statements of cash flow and, promptly after prepared, any other budgets or revised budgets prepared by the Company and approved by the Board of Directors. 

If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period,
the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything else in this Section 7.1 to the contrary, the Company may cease providing the information set forth in this
Section 7.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a Registration Statement if it reasonably concludes it must do so to comply with the SEC rules
applicable to such Registration Statement and related offering; provided that the Company’s covenants under this Section 7.1 shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable
efforts to cause such Registration Statement to become effective. 
 7.2    Inspection Rights. The Company shall
permit each Affiliate Investor to (a) visit and inspect the headquarter of the Company and (b) discuss the business, affairs, finances and accounts of the Group with officers of the Company, in each case during normal business hours and in such
a manner so as not to unreasonably interfere with the normal operations of the Group Companies, provided that each Affiliate Investor shall not exercise such rights more than twice a year. 

7.3    Termination of Information Rights. The covenants set forth in Section 7.1 and Section 7.2 shall
terminate and be of no further force or effect (i) immediately before the consummation of a Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange
Act, or (iii) upon the closing of a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and
Articles., whichever event occurs first. 

  
 -14- 

 7.4    Confidentiality. Each Investor agrees that such Investor
will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of
the Company’s intention to file a Registration Statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 7.4 by
such Investor), (b) is or has been independently developed or conceived by such Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to such Investor by a third party without a
breach of any obligation of confidentiality such third party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other
professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees
to be bound by the provisions of this Section 7.4; (iii) to any Affiliate, partner, member, shareholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor
informs such Person that such information is confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, regulation, rule, court order or subpoena, provided that
such Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. 

ARTICLE VIII. 
 RIGHTS
AND RESTRICTIONS REGARDING SHARE TRANSFERS 
 8.1    Right of First Offer. Subject to the terms and
conditions of this Section 8.1 and applicable securities Laws, if the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to the Investors. Each Investor shall be entitled to
apportion the right of first offer hereby granted to it in such proportions as it deems appropriate, among (i) itself, (ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person
having “beneficial ownership”, as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of the Investor (“Investor Beneficial Owners”); provided
that each such Affiliate or Investor Beneficial Owner (x) is not a Competitor, unless such party’s purchase of New Securities is otherwise consented to by the Board of Directors, (y) agrees to enter into this Agreement as an
“Investor” under such agreement (provided that any Competitor as reasonably determined by the Board of Directors shall not be entitled to any rights under Sections 7.1, 7.2 and 8.1 hereof), and (z) agrees
to purchase at least such number of New Securities as are allocable hereunder to the Investor holding the fewest number of Investor Shares and any other Derivative Securities. 

(a)    The Company shall give notice (the “Offer Notice”) to each Investor, stating (i) its bona
fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities. 

  
 -15- 

 (b)    By notification to the Company within thirty (30) days
after the Offer Notice is given, each Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Ordinary Shares
then held by such Investor (including all Ordinary Shares then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Series A Preferred Shares and any other Derivative Securities then held by such Investor) bears
to the total Ordinary Shares of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Series A Preferred Shares and any other Derivative Securities then outstanding). At the expiration of such 30-day period, the Company shall promptly notify each Investor that elects to purchase or acquire all the shares available to it (each, a “Fully Exercising Investor”) of any other
Investor’s failure to do likewise. During the 10-day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or
acquire, in addition to the number of shares specified above, up to that portion of the New Securities for which the Investors were entitled to subscribe but that were not subscribed for by the Investors which is equal to the proportion that the
Ordinary Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Series A Preferred Shares and any other Derivative Securities then held, by such Fully Exercising Investor bears to the Ordinary
Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Series A Preferred Shares and any other Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such
unsubscribed shares. The closing of any sale pursuant to this Section 8.1(b) shall occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities
pursuant to Section 8.1(c). 
 (c)    If all New Securities referred to in the Offer Notice
are not elected to be purchased or acquired as provided in Section 8.1(b), the Company may, during the 90-day period following the expiration of the periods provided in
Section 8.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer
Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be
deemed to be revived and such New Securities shall not be offered unless first reoffered to the Investors in accordance with this Section 8.1. 

(d)    The right of first offer in this Section 8.1 shall not be applicable to (i) Exempted
Securities (as defined in the Company’s Constitutive Documents), (ii) Ordinary Shares issued in an initial public offering and (iii) equity securities of the Company issued under the Employee Share Option Plan. 

8.2    Right of First Refusal. 

(a)    Notice of Offer. If any holder of Shares (the “Proposed ROFR Seller”) intends to sell all
or any part of the Shares it owns pursuant to a bona fide offer to buy from a Person (the “Proposed ROFR Purchaser”), the Proposed ROFR Seller shall submit a written notice (the “ROFR Notice”) to the Company and the
Investors stating the name of the Proposed ROFR Purchaser, the number of Shares proposed to be sold (the “Offered Shares”), the material terms and conditions, including price, of the proposed sale. The Company shall have fifteen
(15) Business Days from the date of the Proposed ROFR Seller issues the ROFR Notice, which shall be irrevocable for such time, to provide a written offer to the Proposed ROFR Seller to purchase all or any portion of the Offered Shares on terms,
including price, no less favorable to the Proposed ROFR Seller than those reflected in the ROFR Notice. 

  
 -16- 

 (b)    Exercise of Right of First Refusal. If the Company has
not elected to purchase all of the Offered Shares, the Company shall inform the Investors, within fifteen (15) Business Days after the ROFR Notice has been delivered to the Company, in writing of the number of Offered Shares that it has elected
not to purchase, and each Investor that has received such notice from the Company shall have forty-five (45) Business Days from the date the Proposed ROFR Seller issues the ROFR Notice (the “ROFR Holders’ First Refusal
Period”), which shall be irrevocable for such time, to provide a written offer to the Company and the Proposed ROFR Seller to purchase all or part of the remaining of the Offered Shares on terms, including price, no less favorable to the
Proposed ROFR Seller than those reflected in the ROFR Notice (the “ROFR Offer”). Any ROFR Offer shall be irrevocable by the offering Investor and shall constitute a binding agreement. Each ROFR Holder shall have the right to
purchase that number of the Offered Shares, equivalent to the product obtained by multiplying the aggregate number of the Offered Shares, by a fraction, the numerator of which is the number of Ordinary Shares (on an
as-converted basis) held by such ROFR Holder at the time of the transaction and the denominator of which is the total number of Ordinary Shares (on an as-converted
basis) owned by all ROFR Holders at the time of the transaction who have the right of first refusal to purchase the applicable shares and have elected to participate in such right of first refusal purchase. 

(c)    Closing. The closing of any purchase of shares of the Company by a ROFR Holder pursuant to this
Section 8.2(c) (the “ROFR Closing”) shall occur on such date as may be agreed by such ROFR Holder and the Proposed ROFR Seller, but in no event later than seventy-five (75) Business Days after the date
on which the ROFR Notice is deemed to have been accepted. At the ROFR Closing, if all necessary conditions of the ROFR Closing have been satisfied or waived: (i) the Proposed ROFR Seller shall deliver to such ROFR Holder (x) an instrument
of transfer executed by the Proposed ROFR Seller in favor of the ROFR Holder and (y) either an extract of the register of shareholders of the Company, dated as of the date of the ROFR Closing and duly certified by the registered office provider of
the Company, evidencing the ROFR Holder’s ownership of the Offered Shares set out in the ROFR Offer or a certificate or certificates representing the Offered Shares; and (ii) the ROFR Holder shall deliver to the Proposed ROFR Seller the
purchase price for the Offered Shares in cash, by wire transfer of immediately available funds to an account designated by the Proposed ROFR Seller, such account to be designated by the Proposed ROFR Seller no later than five (5) Business Days
prior to the ROFR Closing. 
 (d)    Expiration Notice. Within ten (10) days following the expiration of
the ROFR Holders’ First Refusal Period, the Company will give written notice (the “First Refusal Expiration Notice”) to the Proposed ROFR Seller and the ROFR Holders specifying either (i) that all of the Offered Shares
were subscribed by the ROFR Holders exercising their rights of first refusal, or (ii) that the ROFR Holders have not subscribed for any or all of the Offered Shares in which case the First Refusal Expiration Notice will specify the Co-Sale Pro Rata Portion (as defined below) of the remaining Offered Shares (the “Remaining Shares”) for the purpose of the co-sale right of the Investors
described in the Section 8.3 below. 
 (e)    Exclusions. Notwithstanding
Section 8.2(a), none of the following transactions shall be subject to the right of first refusal described in this Section 8.2: (i) any transfer of Shares by a Founder or an Investor to any
Affiliate of such Founder or such Investor; (ii) any sale in reliance on Rule 144A under the Securities Act; (iii) any sale of shares of the Company pursuant to Rule 144 under the Securities Act; (iv) any sale of shares of the Company
to the public pursuant to a Registration Statement filed with, and declared effective by, the SEC under the Securities Act; and (v) other on-market sales; provided that in each of (ii) and
(iv) above, any such sale shall be (x) to five (5) or more purchasers, none of which shall be Affiliates of any other such purchaser and (y) no more than five percent (5%) of the total number of issued and outstanding Shares on a
fully diluted basis shall be transferred by any seller in any such sale or series of such sales to any purchaser in aggregate with its Affiliates. 

  
 -17- 

 (f)    Subordination. The Investors’ right of first refusal
under this Section 8.2 shall be subordinated to only the Company’s right of first refusal. 

8.3    Co-Sale Right. In the event that any Founder of any Founder Holding
Company proposes to sell any or all of the number of Shares (the “Founders’ Offered Shares”), then the Remaining Shares shall be subject to co-sale rights under this Section 8.3 and each
ROFR Holder who has not exercised any of its right of first refusal with respect to the Founders’ Offered Shares (the “Co-Sale Right Holder”) shall have the right, exercisable upon written
notice to the Proposed ROFR Seller, the Company and each other Co-Sale Right Holder (the “Co-Sale Notice”) within ten (10) Business Days after receipt of
First Refusal Expiration Notice (the “Co-Sale Right Period”), to participate in such sale of the Remaining Shares on the same terms and conditions as set forth in the ROFR Notice. The Co-Sale Notice
shall set forth the number of Ordinary Shares that such Co-Sale Right Holder wishes to include in such sale or transfer, which amount shall not exceed the Co-Sale Pro
Rata Portion (as defined below) of such Co-Sale Right Holder. To the extent one or more of the Co-Sale Right Holders exercise such right of participation in accordance
with the terms and conditions set forth below, the number of Ordinary Shares that such Proposed ROFR Seller may sell in the transaction shall be correspondingly reduced. The co-sale right of each Co-Sale Right Holder shall be subject to the following terms and conditions: 

(a)    Co-Sale Pro Rata Portion. Each
Co-Sale Right Holder may sell all or any part of that number of Ordinary Shares (on an as-converted basis) held by it that is equal to the product obtained by
multiplying (x) the aggregate number of the Remaining Shares subject to the co-sale right hereunder by (y) a fraction, the numerator of which is the number of Ordinary Shares (on an as-converted basis) owned by such Co-Sale Right Holder at the time of the sale or transfer and the denominator of which is the combined number of Ordinary Shares (on an as-converted basis) at the time owned by all Co-Sale Right Holders who elect to exercise their co-sale rights (if any Co-Sale Right Holder does not elect to exercise the co-sale right to the full extent then its Ordinary Shares (on as-converted basis)
for calculation in the denominator shall be proportionately reduced) (“Co-Sale Pro Rata Portion”). 

(b)    Transferred Shares. Each participating Co-Sale Right Holder shall
effect its participation in the sale by promptly delivering to the Proposed ROFR Seller for transfer to the Proposed ROFR Purchaser an executed instrument of transfer and one or more certificates which represent: 

(i)    the number of Ordinary Shares (on an as-converted basis)
which such Co-Sale Right Holder elects to sell; 
 (ii)    that
number of Preferred Shares which is at such time convertible into the number of Ordinary Shares that such Co-Sale Right Holder elects to sell; provided in such case that, if the Proposed ROFR Purchaser
objects to the allotment of Preferred Shares in lieu of Ordinary Shares, such Co-Sale Right Holder shall convert such Preferred Shares into Ordinary Shares and allot Ordinary Shares as provided in
Subsection 8.3(b)(i) above. The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the purchaser; or 

  
 -18- 

 (iii)    a combination of the above. 

(c)    Payment. The share certificate or certificates, together with an instrument of transfer duly executed by
the participating Co-Sale Right Holder, that the participating Co-Sale Right Holder delivers to the Proposed ROFR Seller pursuant to
Section 8.3(b) shall be transferred to the Proposed ROFR Purchaser in consummation of the sale of the Founders’ Offered Shares pursuant to the terms and conditions specified in the ROFR Notice, and the Proposed ROFR
Seller shall concurrently therewith remit to such Co-Sale Right Holder that portion of the sale proceeds to which such Co-Sale Right Holder is entitled by reason of its
participation in such sale. To the extent that any Proposed ROFR Purchaser prohibits such assignment or otherwise refuses to purchase any shares or other securities from a Co-Sale Right Holder exercising its co-sale right hereunder, the Proposed ROFR Seller shall not sell to such Proposed ROFR Purchaser any ROFR Shares unless and until, simultaneously with such sale, the Proposed ROFR Seller shall purchase such shares
or other securities from such Co-Sale Right Holder. 
 (d)    Right to
Transfer. To the extent the ROFR Holders do not elect to purchase, or to participate in the sale of, any or all of the Founders ‘Offered Shares subject to the ROFR Notice, the Proposed ROFR Seller may, not later than ninety
(90) Business Days following delivery to the Company and each of the ROFR Holders of the ROFR Notice, conclude a transfer of the Remaining Shares covered by the ROFR Notice and not elected to be purchased by the ROFR Holders, which in each case
shall be on substantially the same terms and conditions as those described in the ROFR Notice. The Proposed ROFR Seller shall cause any Proposed ROFR Purchaser of such shares to comply with this Agreement and Memorandum and Articles, as maybe
amended from time to time, to the fullest extent. Any proposed transfer on terms and conditions which are materially different from those described in the ROFR Notice, as well as any subsequent proposed transfer of any ROFR Shares by the Proposed
ROFR Seller, shall again be subject to the right of first refusal of the ROFR Holders and the co-sale right of the Co-Sale Right Holders and shall require compliance by
the Proposed ROFR Seller with the procedures described in Sections 8.2 and 8.3 of this Agreement. 

8.4    Prohibited Transfers  

(a)    Subject to Section 8.6, none of the Founder Holding Companies shall sell, assign, transfer, pledge,
hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions, directly or indirectly any Ordinary Shares held by it to any Person on or prior to a Qualified IPO. Any attempt by the Founder Holding Companies to sell or
transfer Ordinary Shares in violation of this Section 8.4 shall be void, and the Company hereby agrees that it will not effect such a transfer nor will it treat any alleged transferee as the holder of such shares. 

  
 -19- 

 (b)    The Founders and the Founder Holding Companies agree that the
restrictions with regard to the transfer of the Founder Holding Companies’ shares in the Company as described under this Section 8.4 shall apply equally to transfer of the shares of the Founder Holding Companies, as if each of the
provisions under this Section 8.4 has been repeated with regard to transfer of the shares of the Founder Holding Companies except that the reference to the shares in the Company has been revised to refer to the shares in the Founder Holding
Companies, as applicable, so that the result of such restrictions on the indirect transfer of the shares in the Company by transferring the shares in the Founder Holding Companies is the same as if the Founder Holding Companies directly transfer the
relevant shares in the Company. 
 8.5    Restrictions on Issuance by Group Company Prior to a Qualified IPO,
the Founders shall not cause any Group Company (other than the Company) to, issue to any Person any equity securities of such Group Company, or any options or warrants for, or any other securities exchangeable for or convertible into, such equity
securities of such Group Company. 
 8.6    Founder Transfers. Notwithstanding anything to the contrary in this
Agreement, the Founders or the Founder Holding Companies may sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions, directly or indirectly no more than five percent (5%) of the
outstanding Shares accumulatively to any party so long as the Founder collectively beneficially own more than fifty percent (50%) of the outstanding Shares following such transfer. 

8.7    Termination of Rights and Restrictions. The covenants set forth in this Article VIII shall terminate
and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or
(iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and Articles., whichever
event occurs first. 
 ARTICLE IX. 

DRAG-ALONG OBLIGATION 

9.1    Drag-Along Rights. 

(a)    If, at any time prior to a Qualified IPO, any Investor (the “Drag-Along Seller”) secures an
irrevocable offer to acquire all share capital or assets of the Company (a “Drag-Along Sale”) with a valuation of the Company of more than US$600,000,000 with any Person (such Person, a “Drag-Along Purchaser”) upon
such terms and conditions as agreed to with the Drag-Along Seller, and such Drag-Along Sale is agreed by a majority vote of the other Investors and a majority vote of the Founders, each other Investor (an “Other Investor”) agrees,
at the request of the Drag-Along Seller, to participate in such Drag-Along Sale as set forth in this Section 9.1. 

  
 -20- 

 (b)    If the Drag-Along Sale is structured as a sale of Shares, each
Other Investor shall sell to the Drag-Along Purchaser all Shares then held by such Other Investor on the same terms and conditions as are applicable to the Drag-Along Seller, including the same per-share
consideration with respect to a specific class of Shares, and shall execute the necessary transfer forms in favor of the Drag- Along Purchaser; provided that the proceeds from such sale of any Round C Investors shall not be less than the
higher of (i) the Series A Liquidation Amount (as defined in the Memorandum and Articles) or (ii) the purchase price as stated in the offer of the Drag-Along Purchaser pro rata based on the number of Ordinary Shares held by such Round C
Investors (on an as-converted basis); provided, further, that except with respect to any liability incurred by such Other Investor individually, such Other Investor shall not be liable to a
Drag-Along Purchaser for an amount greater than the proceeds from such sale. 
 (c)    If the Drag-Along Sale is
structured as a merger, amalgamation or scheme of arrangement of the Company or other transaction that requires the approval of the Investors, each Investor shall vote its respective Shares (or execute and deliver any written consents in lieu
thereof) in favor of any Drag-Along Sale and all actions deemed reasonably necessary by the Drag-Along Seller in connection with the Drag-Along Sale, and against any action or proposal that may prevent, hinder or impede the consummation of the
Drag-Along Sale. 
 (d)    The Drag-Along Seller shall provide written notice of a proposed Drag- Along Sale to the
Other Investors (a “Drag-Along Sale Notice”) not later than ten (10) days prior to such proposed Drag-Along Sale. The Drag-Along Sale Notice shall identify the Drag-Along Purchaser, the
per-Ordinary Share consideration for which a transfer is proposed to be made (the “Drag-Along Sale Price”) and all other material terms and conditions of the Drag-Along Sale. Each Other
Investor shall be required to participate in the Drag-Along Sale on the terms and conditions set forth in the Drag-Along Sale Notice and to tender its Shares. The price and form of consideration payable in such transfer shall be the Drag-Along Sale
Price. 
 (e)    The Drag-Along Seller shall have a period of 180 days from the date of receipt of the Drag-Along Sale
Notice to enter into a definitive agreement providing for the Drag-Along Sale on the terms and conditions set forth in such Drag-Along Sale Notice, which Drag-Along Sale shall be promptly consummated, subject to fulfilling any closing conditions and
obtaining any required regulatory approvals. If the Drag-Along Seller has not entered into a definitive agreement providing for the Drag-Along Sale within such 180-day period and the Drag-Along Seller proposes
to effect a Drag-Along Sale after such 180-day period, the Drag-Along Seller shall again comply with the procedures set forth in this Section 9.1(e). 

(f)    In connection with a Drag-Along Sale, each Other Investor shall (i) make such representations, warranties and
covenants and enter into such definitive agreements as are customary for transactions of the nature of the Drag-Along Sale, (ii) benefit from and be subject to all of the same provisions of the definitive agreements as are applicable to the
Drag-Along Seller, (iii) be required to bear its proportionate share of any escrows, holdbacks or adjustments in respect of the purchase price or indemnification obligations; provided that an Other Investor shall only be obligated to
indemnify any other Person in connection with such Drag-Along Sale severally; provided, further, that no Other Investor shall be obligated to indemnify any other shareholder for any breach or misrepresentation by such other shareholder
with respect to title in such other shareholder’s equity securities, (iv) be required to bear its proportionate share of the costs and expenses incurred by the Company and the Investors in connection with the proposed transaction (whether
or not consummated), including all attorney’s fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions (including, if requested by the Drag-Along Seller, an investment
banking firm selected by the Drag-Along Seller and engaged, on customary terms (including customary indemnification from the Company)), to the extent not paid by the Company, and (v) to the extent permitted by applicable Law, not exercise any
dissenters’ or appraisal rights to which they may be entitled in connection with a Drag-Along Sale. 

  
 -21- 

 9.2    Termination of Drag-Along Rights. The covenants set forth
in Section 9.1 shall terminate and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements
of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as
provided in the Memorandum and Articles., whichever event occurs first. 
 ARTICLE X. 

GOVERNANCE AND ADDITIONAL COVENANTS 

10.1    Board of Directors.  

(a)    As of the Execution Date, the Board of Directors shall consist of the following members: 

 

	 	(i)	 the Chief Executive Officer of the Company; 

 

	 	(ii)	 the Chief Operating Officer of the Company; 

 

	 	(iii)	 one (1) director appointed by the Chief Executive Officer of the Company; 

 

	 	(iv)	 one (1) Round A Director; 

 

	 	(v)	 one (1) Round B Director; and 

 

	 	(vi)	 one (1) Preferred Share Director 

(b)    Each of the Founders and the Affiliate Investors shall take all actions available to it in its capacity as a
shareholder of the Company, to take or cause to be taken all actions available to each that are necessary to maintain the composition of the Board of Directors as set forth in Section 10.1(a). 

(c)    Only the Party who had the power to designate a director pursuant to Section 10.1(a)
shall have the power to remove such director. Each of the Parties hereto agrees to take such action as is necessary to call a special meeting of the shareholders of the Company (or effect a written consent in lieu thereof) for the purpose of
effecting any such removal, and at such meeting each such Party shall vote to accomplish said result. In the event that any director is removed or shall have resigned or become unable to serve, the Party who had the power to designate such director
pursuant to Section 10.1(a) shall have the power to designate a person reasonably qualified to serve on the Board of Directors to fill such vacancy, whereupon each of the Parties hereto, or their successors and assigns,
agree to take such action as is necessary to promptly elect such person to fill such vacancy (including, if necessary, calling a special meeting of the shareholders of the Company (or effect a written consent in lieu thereof) and voting all shares
owned by the Parties hereto to accomplish such result). Except as provided above, no Party shall vote in favor of, or otherwise take any actions in respect of, the removal of any director who shall have been designated or nominated pursuant to
Section 10.1(a). 

  
 -22- 

 (d)    The Board of Directors shall have a Chairman, and each of the
Founders and the Affiliate Investors shall cause its designee directors(s) to support resolutions and actions by written consent of the Board of Directors that maintain or appoint to the position of Chairman of the Board of Directors the Chief
Executive Officer of the Company. 
 (e)    On all actions to be taken and matters to be decided by the Board of
Directors, each director shall be entitled to cast one (1) vote, and subject to Section 10.3, the affirmative vote of the directors having a majority of the total voting power represented at a meeting at which a quorum
is present shall constitute an act of the Board of Directors. In the case of an equality of votes, the Chairman, if any, or in the absence of the Chairman, a director designated by the Board of Directors to preside at a meeting of the Board of
Directors, shall have a second or casting vote in addition to any other vote such person may have. 

10.2    Matters Requiring Requisite Approval. Each of the Company and the Founders hereby covenants and agrees
with each of the Investors that no Group Companies shall take and Founders shall cause each Group Company not to take any of the following actions or effect or agree or commit to do any of the following, in each case directly or indirectly, whether
by merger, consolidation, amalgamation or otherwise without Requisite Approval: 
 (a)    any change in any of the
rights, preferences, privileges or priority of the holders of the Series A Preferred Shares; 
 (b)    authorization,
creation or issuance of any class or series of Shares having any right, preference or priority superior to or on a parity with the Series A Preferred Shares; 

(c)    repurchase or redemption of Shares (other than pursuant to the Company’s Employee Share Option Plan); 

(d)    amendment of any Group Company’s memorandum and articles of association; 

(e)    merger or consolidation of any Group Company; 

(f)    liquidation or dissolution of any of the Group Companies, as well as any Deemed Liquidation Event; and 

(g)    the sale, pledge or other disposition of all or substantially all of the Group Companies’ assets or the
purchase of all or substantially all of the assets of another entity. 

  
 -23- 

 10.3    Matters Requiring Approval of the Board of Directors.

 (a)    Each of the Company and the Founders hereby covenants and agrees with each of the Investors that no Group
Company shall take and Founders shall cause each Group Company not to take any of the following actions or effect or agree or commit to do any of the following, in each case directly or indirectly, whether by merger, consolidation, amalgamation or
otherwise without approval of a majority of the Board of Directors, including the affirmative vote of at least two (2) Investor Directors: 
  

	 	(i)	 the declaration or payment of a dividend on any shares/equity of the Group Companies; 

 

	 	(ii)	 the adoption or amendment of any employee share award plan, including the amendment of the Employee Share
Option Plan; 

  

	 	(iii)	 any material transaction between any Group Company and any of its shareholders, directors, officers, employees
or other insiders and any of their family members or affiliates other than on an arm’s-length basis and upon full disclosure to shareholders including the Investors; 

 

	 	(iv)	 the appointment or removal of the Chief Executive Officer of the Company; 

 

	 	(v)	 any incurrence of debt by any Group Company other than trade debts not exceeding US$10,000,000 in aggregate;

  

	 	(vi)	 adoption of the annual Budget; 

 

	 	(vii)	 appoint or change the auditors of the Company; 

 

	 	(viii)	 the license or transfer of any patents, copyrights, trademarks or other intellectual property rights outside
the normal business operations; 

  

	 	(ix)	 the termination or substantial change of the Company’s main business, or the involvement in any new
business that is significantly different from the current main business; 

  

	 	(x)	 the settlement of any material legal action with a value in access of RMB10,000,000; 

 

	 	(xi)	 any initial public offering plan other than a Qualified IPO; 

 

	 	(xii)	 any increase or decrease to the capital of any of the Group Companies; 

 

	 	(xiii)	 any pledge on material assets of any of the Group Companies; 

 

	 	(xiv)	 any change to the number of directors on the Board of Directors, any change to the rules governing election to
the Board of Directors and any change to the term of service of members of the Board of Directors; 

  
 -24- 

	 	(xv)	 any change to the name of the Company; 

 

	 	(xvi)	 any change to the Control Agreements (as defined in the Series A Share Purchase Agreement) and entering into
any new control agreement by any Group Company; 

  

	 	(xvii)	 any change to the voting rights of any shares of the Company; 

 

	 	(xviii)	 the establishment or cessation of any material business lines carried on by the Company; and

  

	 	(xix)	 any issuance to any Person any equity securities of the Company, or any options or warrants for, or any other
securities exchangeable for or convertible into, such equity securities of the Company, except for any issuance pursuant to (x) the Series A Share Purchase Agreement or Round A and B Share Subscription Agreement, (y) the Company’s
Employee Share Option Plan, or (z) the initial public offering. 

 (b)    Each of the Investors
and Founder Holding Companies hereby covenants and agrees that it shall not undertake any pledge over its Shares without approval of a two-thirds majority of the Board of Directors. 

10.4    Insurance. The Company shall obtain, upon the completion of a Qualified IPO, from financially sound and
reputable insurers, directors and officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts to cause such insurance policy to be maintained until such
time as the Board of Directors (including the affirmative votes by at least two (2) Investor Directors) determines that such insurance should be discontinued. 

10.5    Termination of Covenants. The rights and covenants set forth in this Article X (but with respect to
Section 10.4) shall terminate and be of no further force or effect (i) immediately before the consummation of a Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of
Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined in the Memorandum and Articles) and the remaining assets distribution as
provided in the Memorandum and Articles., whichever event occurs first. 
 ARTICLE XI. 

CONFIDENTIALITY 

11.1    Confidentiality. 

(a)     Subject to Section 11.1(b): 

 

	 	(i)	 each of the Parties shall treat as strictly confidential and not disclose or use any documents, materials and
other information, in whatever form, whether technical or commercial, received or obtained by it prior to entering into this Agreement or as a result of entering into this Agreement, in each case which relates to: 

 

	 	(A)	 the provisions of this Agreement and any agreement entered into in relation to this Agreement; or

  
 -25- 

	 	(B)	 the negotiations relating to this Agreement (and any other agreements entered into in relation to this
Agreement); 

  

	 	(ii)	 each Party shall treat as strictly confidential and not disclose or use any information relating to the
business, financial or other affairs (including future plans and targets) of any other Party or any member of their group; 

  

	 	(iii)	 each Party shall treat as strictly confidential and not disclose or use any information relating to the
business, financial or other affairs (including future plans and targets) of the Company. 

(b)    Section 11.1(a) shall not prohibit disclosure or use of any information if and to the
extent: 
  

	 	(i)	 the disclosure or use is required by law, any regulatory body or any recognized stock exchange on which the
shares of any Party are listed; 

  

	 	(ii)	 the disclosure or use is required to vest the full benefit of this Agreement in any Party;

  

	 	(iii)	 the disclosure or use is required for the purpose of any judicial proceedings arising out of this Agreement or
any other agreement entered into under or pursuant to this Agreement or the disclosure is made to a Taxing Authority in connection with the Tax affairs of the disclosing Party; 

 

	 	(iv)	 the disclosure is made to professional advisers or actual or potential financiers of any Party on a need-to-know basis and on terms that these professional advisers or actual or potential financiers undertake to comply with the provisions of
Section 11.1(a) in respect of such information as if they were a party to this Agreement; 

  

	 	(v)	 the information is or becomes publicly available (other than by breach of this Agreement);

  

	 	(vi)	 the disclosure is made on a confidential basis to potential purchasers of all or part of any Party or to their
professional advisers or financiers; provided that any of these persons need to know the information for the purposes of considering, evaluating, advising on or furthering the potential purchase; 

 

	 	(vii)	 the other Party has given prior written approval, such approval not to be unreasonably withheld or delayed, to
the disclosure or use (including, without limitation, disclosure or use for the purposes of publicizing the transactions the subject of this Agreement or any other document drafted in connection with a Qualified IPO); or 

  
 -26- 

	 	(viii)	 the information is independently developed after the closing of the Qualified IPO; 

provided that, prior to disclosure or use of any information pursuant to Section 11.1(b)(i), (ii) or (iii), the
Party concerned shall promptly notify the other Parties of these requirements with a view to providing the other Parties with the opportunity to contest such disclosure or use or otherwise to agree on the timing and content of such disclosure or
use. 
 (c)    A recipient of confidential information may disclose such confidential information to its shareholders,
employees, directors, representatives and agents only to the extent reasonably necessary for the achievement of the objectives of this Agreement and the other documents drafted in connection with a Qualified IPO. A recipient of information shall
ensure that its relevant shareholders, employees, directors, representatives and agents are aware of and comply with the confidentiality obligations set out in this Article XI. 

11.2    Damages Not an Adequate Remedy. Without prejudice to any other rights or remedies which a Party may have,
the Parties acknowledge and agree that damages would not be an adequate remedy for any breach of this Article XI and the remedies of injunction, specific performance and other equitable relief are appropriate for any threatened or actual
breach of this provision and no proof of special damages shall be necessary for the enforcement of the rights under this Article XI. 

11.3    Survival. 

(a)    The disclosing Party shall remain responsible for any breach of this Article XI by the person to whom that
confidential information is disclosed. 
 (b)    The provisions of this Article XI shall survive the termination
of this Agreement for whatever cause. 
 ARTICLE XII. 

NON-COMPETITION; NON-SOLICITATION 

12.1    Non-Competition. 

 

	 	(a)	 Until the third (3rd) anniversary of the Execution Date, 

 

	 	(i)	 no Founder or Founder Holding Company shall, directly or indirectly, conduct, manage, invest in, control or own
any Competitor, unless such Founder or Founder Holding Company has first obtained the consent of a majority of the Investor Directors; and 

  
 -27- 

	 	(ii)	 each Founder and Founder Holding Company shall cause each of the directors and members of the senior management
of the Company to comply with the obligations of Section 12.1(a)(i); 

(b)    provided that the provisions of this Section 12.1 shall not prohibit the
acquisition of any Founder Holding Company by any Competitor as long as no employee of the Founder Holding Company becomes actively engaged in the management or operation of such Competitor; provided, further, that the foregoing shall
not limit the ability of the Founders, Founder Holding Companies and their respective Affiliates to engage in activities expressly contemplated by this Agreement. 

(c)    If a judicial or arbitral determination is made that any of the provisions of this
Section 12.1 constitutes an unreasonable or otherwise unenforceable restriction against any Founder, the provisions of this Section 12.1 shall be rendered void only to the extent that such judicial
or arbitral determination finds the provisions to be unreasonable or otherwise unenforceable. In that regard, the Parties hereby agree that any judicial or arbitral authority construing this Agreement shall be empowered to sever any prohibited
business activity, time period or geographical area from the coverage of this Section 12.1 and to apply the provisions of this Section 12.1 to the remaining business activities, time periods or
geographical areas not severed by such judicial or arbitral authority. The time period during which the prohibitions set forth in this Section 12.1 shall apply shall be tolled and suspended for a period equal to the
aggregate quantity of time during which any Founder violates such prohibitions in any respect. 
 12.2    Non-Solicitation. Until the second (2nd) anniversary of the Execution Date, no entity or business directly or indirectly controlled by any Founder shall, directly or indirectly, (i) solicit for employment
or any similar arrangement any Founder or (ii) hire any Founder; provided, however, that this Section 12.2 shall not apply to Founders whose employment has been terminated by the Company and its Affiliates and clause
(i) hereof shall not prohibit general solicitations for employment through advertisements or other means not targeted specifically to Founders. 

ARTICLE XIII. 

MISCELLANEOUS AND GENERAL 

13.1    Amendment; Waiver. Any provision of this Agreement may be amended or waived if, and only if, such
amendment or waiver is in writing and signed, in the case of an amendment, by each Party, or in the case of a waiver, by the Party against whom the waiver is to be effective. No failure or delay by any Party in exercising any right, power or
privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by Law except as otherwise specifically provided in this Section 13.1. 

  
 -28- 

 13.2    Counterparts. This Agreement may be executed in any
number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement. 

13.3    Governing Law and Venue; Specific Performance. 

(a)    THIS AGREEMENT SHALL BE GOVERNED BY AND INTERPRETED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK (INCLUDING SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW), WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW RULES THEREOF THAT WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAW OF ANY OTHER
JURISDICTION. 
 (b)    Subject to Section 13.3(c), any disputes, actions and proceedings
against any Party or arising out of or in any way relating to this Agreement shall be submitted to the HKIAC and resolved in accordance with the Arbitration Rules in force at the relevant time, except as such rules are modified or displaced by any
of the provisions of this Agreement. The official language of the arbitration shall be English and the arbitration tribunal shall consist of three arbitrators (each, an “Arbitrator”). The claimant(s), irrespective of number, shall
nominate jointly one Arbitrator; the respondent(s), irrespective of number, shall nominate jointly one Arbitrator; and a third Arbitrator will be nominated jointly by the first two Arbitrators and shall serve as chairman of the arbitration tribunal.
In the event the claimant(s) or respondent(s) or the first two Arbitrators shall fail to nominate or agree to the joint nomination of an Arbitrator or the third Arbitrator, as applicable, within the time limits specified by the Arbitration Rules,
such Arbitrator shall be appointed promptly by the HKIAC. The arbitration tribunal shall have no authority to award punitive or other punitive-type damages. The award of the arbitration tribunal shall be final and binding upon the disputing parties.
Any party to an award may apply to any court of competent jurisdiction for enforcement of such award and, for purposes of the enforcement of such award, the Parties irrevocably and unconditionally submit to the jurisdiction of any court of competent
jurisdiction and waive any defenses to such enforcement based on lack of personal jurisdiction or inconvenient forum. 

(c)    Notwithstanding the foregoing, the Parties hereby consent to and agree that in addition to any recourse to
arbitration as set out in this Section 13.3, any Party may, to the extent permitted under the Laws of the jurisdiction where application is made, seek an interim injunction from a court or other authority with competent
jurisdiction and, notwithstanding that this Agreement is governed by the Laws of the State of New York, a court or authority hearing an application for injunctive relief may apply the procedural law of the jurisdiction where the court or other
authority is located in determining whether to grant the interim injunction. For the avoidance of doubt, this Section 13.3(c) is only applicable to the seeking of interim injunctions and does not restrict the application of
Section 13.3(b) in any way. 
 (d)    The Parties agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent
breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court having jurisdiction, this being in addition to any other remedy to which such Party is entitled at law or in equity. 

  
 -29- 

 13.4    Notices. Any notice, request, instruction or other
document to be given hereunder by any Party to any other Party shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by facsimile, e-mail or overnight courier:

 If to the Investors, to the address listed in Exhibit A for each Investor. 

If to the Company: 
 ECMOHO
Limited 
 2F/3F, Xuhuiyuan Building No. 1000, 

Tianyaoqiao Road, Xuhui District, 

Shanghai, People’s Republic of China. 

Attention: Richard Wei 
 e-mail: richard@ecmoho.com 
 (with a copy to 

Sullivan & Cromwell, 

Level 32, 
 101 Collins
Street, 
 Melbourne, Victoria 3000 

Australia. 
 Attention: Robert
Chu 
 fax: (+61-3) 9654-2422) 

email: chur@sullcrom.com) 
 or to such other
Person or addresses as may be designated in writing by the Party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving Party upon actual receipt,
if delivered personally, three (3) Business Days after deposit in the mail if sent by registered or certified mail, or upon confirmation of successful transmission if sent by facsimile or e-mail;
provided that if given by facsimile or e-mail, such notice, request, instruction or other document shall be confirmed by the receiving party within one (1) Business Day of receipt by dispatch
pursuant to one of the other methods described herein or on the next Business Day after deposit with an overnight courier. 

  
 -30- 

 13.5    Entire Agreement. This Agreement (including any annex
hereto) constitutes the entire agreement and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the Parties, with respect to the subject matter hereof. EACH PARTY AGREES THAT, EXCEPT
FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT, NEITHER THE INVESTORS NOR THE COMPANY MAKES OR RELIES ON ANY OTHER REPRESENTATIONS, WARRANTIES OR INDUCEMENTS, AND EACH HEREBY DISCLAIMS ANY OTHER REPRESENTATIONS, WARRANTIES OR
INDUCEMENTS, EXPRESS OR IMPLIED, AS TO THE ACCURACY OR COMPLETENESS OF ANY OTHER INFORMATION, MADE BY, OR MADE AVAILABLE BY, ITSELF OR ANY OF ITS REPRESENTATIVES, WITH RESPECT TO, OR IN CONNECTION WITH, THE NEGOTIATION, EXECUTION OR DELIVERY OF THIS
AGREEMENT, NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE OTHER PARTY OR THE OTHER PARTY’S REPRESENTATIVES OF ANY DOCUMENTATION OR OTHER INFORMATION WITH RESPECT TO ANY ONE OR MORE OF THE FOREGOING; PROVIDED, HOWEVER, THAT NONE
OF THE FOREGOING SHALL OPERATE TO LIMIT THE LIABILITY OF ANY OTHER PERSON IN RESPECT OF ANY CLAIM OR CAUSE OF ACTION BASED ON OR ARISING OUT OF FRAUD. NO PARTY SHALL BE BOUND BY, OR BE LIABLE FOR, ANY ALLEGED REPRESENTATION, PROMISE, INDUCEMENT OR
STATEMENT OF INTENTION NOT CONTAINED HEREIN. 
 13.6    No Third-Party Beneficiaries. Each Party hereby agrees
that its respective representations, warranties and covenants set forth herein are solely for the benefit of the other Party, in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer
upon any Persons other than the Parties any rights or remedies hereunder, including the right to rely upon the representations, warranties and indemnities set forth herein. 

13.7    Severability. The provisions of this Agreement shall be deemed severable and the invalidity or
unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or
unenforceable, (i) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (ii) the remainder of
this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such
provision, or the application of such provision, in any other jurisdiction. 
 13.8    Assignment. This
Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of the Parties. No Party may assign any of its rights or delegate any of its obligations under this Agreement, by operation of Law or otherwise, without
the prior written consent of the other Party, except that the Investor may assign any of its rights and obligations under this Agreement to any of its Affiliates (other than the Company or any of its Subsidiaries) to whom it has transferred
Registrable Investor Shares without the prior written consent of the Company (each, an “Affiliate Transferee”); provided that such Affiliate shall as a condition of effectiveness of such assignment duly execute a joinder
agreement substantially in the form of Exhibit B, whereupon such Affiliate shall have the benefits of, and shall be subject to the obligations under, this Agreement as if such Affiliate was originally included in the definition of Investor
herein and had originally been a Party hereto. 

  
 -31- 

 13.9    Fulfillment of Obligations. Any obligation of any Party
to any other Party under this Agreement, which obligation is performed, satisfied or fulfilled completely by an Affiliate of such Party, shall be deemed to have been performed, satisfied or fulfilled by such Party. 

13.10    Termination. Except as otherwise provided in this Agreement, this Agreement will terminate in respect of
all the Parties at the earliest to occur of: (a) each Party agrees in writing to terminate this Agreement; and (b) upon the closing of a Deemed Liquidation Event and completion of the payment of the Series A Liquidation Amount (as defined
in the Memorandum and Articles) and the remaining assets distribution as provided in the Memorandum and Articles. Notwithstanding the foregoing, the termination of this Agreement shall not affect (x) the rights perfected or the obligations
incurred by the Parties prior to such termination (including liability for breach of this Agreement) and (y) the rights and obligations of the Parties under Article VII and Section 6.1. 

[Signature Page Follows] 

  
 -32- 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	ECMOHO Limited
		
	By:	 	 /s/ ZENG QINGCHUN
(曾庆春)

		 	Name: ZENG QINGCHUN (曾庆春)
		 	Title:

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	ECMOHO (HONG KONG)
	HEALTH TECHNOLOGY LIMITED

 
			
		
	By:	 	 /s/ ZENG QINGCHUN
(曾庆春)

		 	Name: ZENG QINGCHUN (曾庆春)
		 	Title:

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	SHANGHAI ECMOHO HEALTH
	BIOTECHNOLOGY CO., LTD.

 
			
		
	By:	 	 /s/ WANG YING (王影)

		 	Name: WANG YING (王影)
		 	Title:

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	BEHEALTH LIMITED
		
	By:	 	 /s/ WANG YING (王影)

		 	Name: WANG YING (王影)
		 	Title:

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	UHEALTH LIMITED
		
	By:	 	 /s/ ZENG QINGCHUN
(曾庆春)

		 	Name: ZENG QINGCHUN (曾庆春)
		 	Title:

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	By:	 	 /s/ WANG YING (王影)

		 	Name: WANG YING (王影)
		 	PRC ID Number: ***

  

[Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	By:	 	 /s/ ZENG QINGCHUN
(曾庆春)

		 	Name: ZENG QINGCHUN (曾庆春)
		 	PRC ID Number: ***

  

[Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	Delta Capital Growth Fund II, L.P.
		
	By:	 	 /s/ Weigang Greg Ye

	Name: Weigang Greg Ye
	Title: Managing Director

  

[Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	李水蓮
		
	By:	 	 /s/ Shua-Lien Li

  

[Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	 Investor:
 CID GREATER
CHINA FUND V, L.P.

		
	By:	 	 /s/ Steven C.Y. Chang

		 	Name: Steven C.Y. Chang
		 	Title: Director

  

[Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above.     
  

			
	Investor:
	STCH INVESTMENT INC.
		
	By:	 	 /s/ Steven C.Y. Chang

		 	Name: Steven C.Y. Chang
		 	Title:   Director

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	Investor:
	SMART WARRIOR LIMITED
		
	By:	 	 /s/ NG Yum Fai

		 	Name: NG Yum Fai
		 	Title:   Director

 [Signature Page to Investors Rights Agreement] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first written above. 
  

			
	Investors:
	
	Canarywharf Capital Limited
		
	By:	 	 /s/ YIJUN TANG

		 	Name: YIJUN TANG
		 	Title:   Director

 [Signature Page to Investors Rights Agreement] 

 
	
	BEST WINNER LIMITED
	
	 /s/ Cheng Yan

	
	Name (print):
	
	Title: Director

 [Signature Page to Investors Rights Agreement] 

 
	
	LAKE ZURICH PARTNERS
	
	 /s/ Yu Jun

	
	Name (print): Yu Jun
	
	Title: Director

 [Signature Page to Investors Rights Agreement] 

 
	
	LIBERAL RICH LIMITED
	
	 /s/ Xingmei Cui

	
	Name (print):
	
	Title: Director

 [Signature Page to Investors Rights Agreement] 

 EXHIBIT A 

SCHEDULE OF INVESTORS 

  
 A-1 

					
	 Investor
	  	 Address of Investor
	  	 Type of Share

	Delta Capital Growth Fund II, L.P.	  	392 Jian Guo West Road, Shanghai, China	  	 Series A Preferred Shares
  

Class A Ordinary Shares

			
	李水蓮	  	台灣省桃園市蘆竹區南祥路 133
號 19 樓,郵遞區號 33854	  	 Series A Preferred Shares
  

Class A Ordinary Shares

			
	CID Greater China Fund V, L.P.	  	 190 Elgin Avenue, George

Town, Grand Cayman, KY1-
 9005,
Cayman Islands
	  	 Class A-1 Ordinary Shares

 
 Class A-2
Ordinary Shares

			
	STCH Investment, Inc.	  	 190 Elgin Avenue, George

Town, Grand Cayman, KY1-
 9005,
Cayman Islands
	  	 Class A-1 Ordinary Shares

 
 Class A-2
Ordinary Shares

			
	Smart Warrior Limited	  	 Vistra Corporate Services

Centre, Wickham’s Cay II,

Tortola, VG 1110, British Virgin

Islands
	  	Class A-2 Ordinary Shares
			
	Canarywharf Capital Limited	  	 Coastal Building, Wickham’s

Cay II, P.O. Box 2221, Road
 Town,
Tortola, British
 Virgin Islands
	  	Class A-2 Ordinary Shares
			
	Behealth Limited	  	 2F/3F, Xuhuiyuan Building

No. 1000, Tianyaoqiao Road,

Xuhui District, Shanghai,

People’s Republic of China
	  	 Class A Ordinary Shares
  

Class B Ordinary Shares

			
	Uhealth Limited	  	 2F/3F, Xuhuiyuan Building

No. 1000, Tianyaoqiao Road,

Xuhui District, Shanghai,

People’s Republic of China
	  	Class B Ordinary Shares
			
	Best Winner Limited	  	 c/o Hermes Corporate

Services Ltd., Fifth Floor,
 Zephyr
House, 122 Mary
 Street, George Town, P.O.

Box 31493, Grand Cayman
 KY1-1206, Cayman Islands
	  	Class A Ordinary Shares
			
	Liberal Rich Limited	  	 Intershore Chambers, Road

Town, Tortola, British Virgin Islands
	  	Class A Ordinary Shares
			
	Lake Zurich Partners	  	 c/o Hermes Corporate

Services Ltd., Fifth Floor,
 Zephyr
House, 122 Mary
 Street, George Town, P.O.

Box 31493, Grand Cayman
 KY1-1206, Cayman Islands
	  	Class A Ordinary Shares

  
 A-2 

 EXHIBIT B 

FORM OF JOINDER AGREEMENT 

THIS JOINDER (this “Joinder”) to the Investors Rights Agreement (the “Agreement”), dated as of August 7,
2018, made by and between ECMOHO Limited, an exempted company incorporated under the Laws of Cayman Islands (the “Company”), each of the investors listed on Exhibit A attached to that Agreement (each, an
“Investor” and together the “Investors”) and certain other parties, is made and entered into as of [●], by and among [●] (the “Holder”), the Company and the Investors. Capitalized terms
used but not otherwise defined herein shall have the meanings set forth in the Agreement. 
 WHEREAS, the Holder desires to acquire certain
Shares from [specified investor]. 
 NOW, THEREFORE, in consideration of the representations,
warranties and covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Joinder hereby agree as follows: 

1.    Agreement to be Bound. The Holder hereby agrees that upon execution of this Joinder, the Holder shall become
a party to the Agreement and shall be fully bound by, and subject to, all of the covenants, terms and conditions of the Agreement as though the Holder was [specified investor] on the date thereof and shall be deemed to
be [specified investor] for all purposes thereof. 
 2.    Representations and
Warranties of the Holder. By executing and delivering this Joinder, the Holder represents and warrants that the Holder is an Affiliate of [specified investor]. 

3.    Counterparts. This Joinder may be executed in separate counterparts, including by facsimile, each of which
shall be an original and all of which taken together shall constitute one and the same agreement. 

4.    Notices. For purposes of Section 13.4 of the Agreement, all notices, demands or
other communications to the Holder shall be directed to: 
 [Name] 

[Address] 
 [Attention] 

[Facsimile Number] 

5.    Governing Law. THIS JOINDER SHALL BE GOVERNED BY AND INTERPRETED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK (INCLUDING SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW), WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW RULES THEREOF THAT WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAW OF
ANY OTHER JURISDICTION. 

  
 B-1 

 6.    Descriptive Headings. The descriptive headings of this
Joinder are inserted for convenience only and do not constitute a part of this Joinder. 
 ***** 

IN WITNESS WHEREOF, the parties hereto have executed this Joinder as of the date first written above. 

 

			
	[Holder]

 
			
		
	By:	 	  

	Name:	 	
	Title:	 	

  

			
	Acknowledged and agreed by:
	
	ECMOHO Limited
		
	By:	 	
                     
                                        

	Name:	 	
	Title:	 	
	
	[Investors]
		
	By:	 	
                     
                                        

	Name:	 	
	Title:	 	

  
 B-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]